Injurious compression induced apoptosis in articular cartliage by Loening, Andreas Markus, 1975-
Injurious Compression Induced Apoptosis in Articular
Cartilage
by
Andreas Markus Loening
Submitted to the Department of Electrical Engineering and Computer
Science
in partial fulfillment of the requirements for the degree of
Master of Engineering in Electrical Engineering and Computer Science
at the
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
February 1999
@ Massachusetts Institute of Technology 1999. All rights reserved.
A uthor................. . ......................... . ..............
Departmezt of Electrical Enginee g an omputer Science
December 21, 1998
Certified by ....... ....... ............... ...................
Alan J. Grodzinsky
Professor of Electrical, Mechanical, and Bioengineering
Thesis Supervisor
Accepted by........ ..............
Arthur C. Smith
Chairman, Department Committee on Graduate Students
MASSACHUSETTS
OF TE
ENG
YRIES
Injurious Compression Induced Apoptosis in Articular Cartilage
by
Andreas Markus Loening
Submitted to the Department of Electrical Engineering and Computer Science
on December 21, 1998, in partial fulfillment of the
requirements for the degree of
Master of Engineering in Electrical Engineering and Computer Science
Abstract
Increased numbers of apoptotic cells have been identified in OA cartilage, and it has been
suggested that apoptosis may play an important role in the pathogenesis of OA. Autora-
diography studies of injuriously compressed normal cartilage tissue have shown subpopu-
lations of cells exhibiting little or no matrix turnover and condensed nuclei suggestive of
apoptotic cell death. The objectives of this thesis were to determine if mechanical loading
could induce apoptosis in non-arthritic cartilage in vitro, and to compare any mechanically
induced apoptosis with other markers of tissue injury. Bovine cartilage was subjected to
unconfined compression-release cycles producing peak stresses of 0-20 MPa. Tissue was
stained via TUNEL for apoptotic nuclei and via ethidium bromide/fluorescein diacetate for
viability. Additionally, wet weight changes, sulfated glycosaminoglycan (sGAG) loss, and
nitric oxide (NO) release were measured. Compression of explants to just 4.5 MPa peak
applied stress produced a significant increase in the number of nuclei staining positive for
apoptosis via TUNEL. A dose dependent response was seen, with ~50% of chondrocytes
staining positive for apoptosis following a 20 MPa compression. Changes in cell viability
corresponded closely with those of the TUNEL assay. Wet weight changes and sGAG loss
also increased in a dose-dependent manner and were indicative of collagen network dam-
age from the injury. NO release increased for only the most severely compressed condition
(20 MPa). In summary, mechanical injury of articular cartilage tissue was found to induce
chondrocytic apoptosis. Additionally, this effect was observable at injury levels (4.5 MPa)
below what was needed to induce detectable effects in wet weight (13 MPa), sGAG re-
lease(6 MPa), and viability (10 MPa). This suggests that programmed cell death may be
one of the earliest events in response to injury of articular cartilage and could hypotheti-
cally lead to subsequent tissue degeneration due to tissue hypocellularity. An alternative
interpretation is that the in vitro mechanical injury could be more representative of fibril-
lated tissue and be interpreted as evidence of apoptosis as a secondary effect of fibrillation,
perhaps relevant to the OA process.
Thesis Supervisor: Alan J. Grodzinsky
Title: Professor of Electrical, Mechanical, and Bioengineering
2
Acknowledgments
I'd like to begin by thanking Al. I've truly appreciated him as an advisor. He's given me
the opportunity to start off on something sort of new and the freedom to figure things out
on my own. When I wandered into his office two and a half years ago, looking for what
began as a UROP, he started talking to me like I already had the job. I never got around to
saying "no thank you" and I'm glad I didn't.
I'd like to thank Mike Lark, Mark Nuttall (two l's), Alison Badger, and Ian James. They
formed the SmithKline contingent that guided much of this research and they provided
more then their fair share of valuable insight and knowledge. I'm especially grateful to
Ian James, who got to do the "phun" (that's fun with a "ph") grundge work of infinite
sectioning and TUNEL of the cartilage disks. Without Ian, there would be no thesis.
Marc Levenston did the greater portion of the biomechanical work that is in appendix: C.
He also taught me first hand what it takes to be a good scientist. I'm sincerely glad falling
asleep while Marc was talking in my initial interview didn't reflect badly enough on me
to deny me the UROP. Stephanie Soohoo helped in running some of the experiments that
became appendix: C and kept me entertained. Han-Hwa helped an immeasurable amount
with a failed attempt at using agarose gel electrophoresis (appendix: D). Additionally, she
taught me almost everything I know about cell-culture and cell isolation and kept the lab
running smoothly. Deb Zamble provided the cisplatin treated cells that provided the only
positive laddering on agarose gels (appendix: D). Rusty Sammon was my roommate and
project partner for 6.344 and is partially responsible for what became appendix: B.
Thanks to Vicki, who has served as the chief listener of my complaints, accusations, and
irrelevant bitching over the past year and a half, a role that no one in this world would
envy, trust me. She also proof-read my thesis, giving her the distinction of being the only
person who will ever read my thesis cover to cover. Cyndi tried doing some histology on
some of my samples and made "the super corer" for which every calf person in this lab
is supremely indebted. She's been a great office mate and advisor, and I can't thank her
enough for getting me into kayaking.
Thanks to Linda, who made me feel at home with my own tendency toward potty mouth.
She also babied me by keeping the FedEx system a black-box abstraction to my eyes. Eliot
saved me a load of work by incorporating my little hardware feedback circuit into the main
incustat hardware himself (and doing a great job of it). He also built the machine that my
thesis is based upon and kept a watchful eye on my ORS abstract as it headed out the door.
Paula gave me advice, encouragement, wisdom, and again, encouragement. She's been a
great source of friendship and conned me into learning scuba diving (yeah, 45'F water,
warm, if you break in your wet suit) Steve gave me advice on my thesis and kept me
entertained on long, boring nights as we both struggled with moving thought to expression.
Bodo provided convincing evidence of what it really means to be a German. Additionally,
Emo, Parth, Moonsoo, Fen, Bryant, Jeff, and JT all provided the vibrant background that
keeps this lab alive.
Thanks to Andrea Pomrehn, Mike Marino, and Tomas Perez for randomly timed intellec-
3
tual conversations on biology that made me interested enough in the subject to "bend to the
darkside" and get my feet wet (and drown in it too).
I'd of course like to thank my parents for reasons to numerous to list.
Finally, thanks to Aaron McCabe, who helped in making my undergraduate years tolerable
and initially got me interested in bioengineering. 5.12 6.001, 6.002, 6.003, 6.004, 6.011,
6.012, 6.013, 6.023 6.041, 6.121, 6.241, 6.302, 6.344, 8.01, 8.02, and 18.04.... that's a lot
of shared pain.
Further Acknowledgements
You guys are electrical engineers, why don't you design something with so-
cially redeeming value? - Chris Benton, on the topic of television.
No matter what you engineer; people will find a way to put porn and commer-
cials on it. -Rusty Sammon, on the topic of socially redeeming engineering.
Yeah, but you can get a job - Aaron McCabe, on why EE is better then Bio.
Yeah, I could finite element model your body, but it's not going to get me layed
- Anonymous, on the merits of finite eliminate modeling.
Calibration of the incustat is a symphonic blend of engineering handwaiving
and total bullshit - Me, on my first attempt at a description of calibrating the
incustat.
Garbage people help people too, they take away our crap. The world would
suck if we didn't have garbage people. - Paula Ragan, on why all professions
are important.
Funding Funding for this work was provided by SmithKline Beecham Pharmaceuticals
and NIH grant AR33236.
4
Contents
1 Introduction and Background 13
1.1 Articular Cartilage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.1.1 Molecular Composition . . . . . . . . . . . . . . . . . . . . . . . 15
1.1.2 Cellular Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.2 Osteoarthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.3 Chondrocyte Response to Mechanical Loading . . . . . . . . . . . . . . . 18
1.4 Processes for Cell Death . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.4.1 Necrosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
1.4.2 Apoptosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
1.4.2.1 Causative Agents . . . . . . . . . . . . . . . . . . . . . 20
1.4.2.2 Signal Transduction . . . . . . . . . . . . . . . . . . . . 21
1.4.2.2.1 CD95 . . . . . . . . . . . . . . . . . . . . . . 23
1.4.2.2.2 TNF . . . . . . . . . . . . . . . . . . . . . . . 23
1.4.2.2.3 Other Signaling Proteins . . . . . . . . . . . . 24
1.4.2.3 Mitochondrial Roles . . . . . . . . . . . . . . . . . . . . 24
1.4.2.4 Caspases . . . . . . . . . . . . . . . . . . . . . . . . . . 25
1.4.2.5 Other Apoptosis Associated Proteins . . . . . . . . . . . 27
1.4.2.6 Cellular Effects . . . . . . . . . . . . . . . . . . . . . . 28
1.4.2.6.1 Phosphatidylserine Translocation . . . . . . . . 28
1.4.2.6.2 Chromosomal DNA Cleavage . . . . . . . . . . 28
1.4.2.6.3 Apoptotic Body Formation . . . . . . . . . . . 31
1.5 Thesis Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2 Materials and Methods 33
2.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.2.1 Tissue Protocols . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.2.1.1 Tissue Harvesting . . . . . . . . . . . . . . . . . . . . . 34
2.2.1.2 Feeding . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.2.2 Injurious Compression Protocols . . . . . . . . . . . . . . . . . . . 35
5
2.2.3 Biochemical Assays . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.3.1 Wet Weight Measurements . . . . . . . . . . . . . . . . 37
2.2.3.2 Sulfated GAG Assay . . . . . . . . . . . . . . . . . . . . 37
2.2.3.3 NO Assay . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.3.4 Apoptosis Assays . . . . . . . . . . . . . . . . . . . . . 38
2.2.3.5 Red/Green Fluorescence Cell Viability Assay . . . . . . 38
2.3 Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3 Results of Injurious Compression on Articular Cartilage 41
3.1 Effects on Cellular Viability . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.1.1 Apoptotic Response . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.1.1.1 Induction of Apoptosis . . . . . . . . . . . . . . . . . . 41
3.1.1.2 Effects of Apoptosis Inhibitors . . . . . . . . . . . . . . 44
3.1.1.3 Effects of Apoptosis Inducing Cytokines . . . . . . . . . 45
3.1.2 General Viability Changes . . . . . . . . . . . . . . . . . . . . . . 46
3.1.2.1 Results of Cell Viability Assay . . . . . . . . . . . . . . 46
3.2 Effects on Tissue Properties . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2.1 Biochemical Changes . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2.1.1 Wet Weight . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2.1.2 Sulfated GAG Loss . . . . . . . . . . . . . . . . . . . . 49
3.2.1.3 Nitric Oxide Release . . . . . . . . . . . . . . . . . . . . 54
4 Discussion and Conclusion 59
4.1 Apoptosis Findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.2 Viability Findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.3 Changes in Biochemical Properties . . . . . . . . . . . . . . . . . . . . . . 61
4.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.5 Future Experiments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
A The Incustat and its Controller 65
A. 1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
A.2 Non-linearities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
A.3 Feedback Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
A.4 Software Issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
A.5 Calibration Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
B Quantitative Analysis of Ethidium Bromide and Fluorescein Diacetate Stained
Cartilage Tissue Sections 75
B. 1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
B.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
6
. . . . . . . . . . . . . . . . . . . . . . . . . 7 9
B.4 Conclusion . . . . . . . . . . . . . . . . . . . . . .
C Biomechanical Characterization of Loaded Disks
C. 1 Introduction . . . . . . . . . . . . . . . . . . . . . .
C.2 Methods . . . . . . . . . . . . . . . . . . . . . . . .
C .3 Results . . . . . . . . . . . . . . . . . . . . . . . . .
C.3.1 Equilibrium Moduli . . . . . . . . . . . . .
C.3.2 Dynamic Stiffness . . . . . . . . . . . . . .
C.3.3 Other Measurements . . . . . . . . . . . . .
C.4 Conclusion . . . . . . . . . . . . . . . . . . . . . .
D Preliminary Results: Other Assays for Apoptosis
D. 1 Flow Cytometry of TUNEL stained cells . . . . . . .
D. 1.1 Introduction . . . . . . . . . . . . . . . . . .
D. 1.2 Materials and Methods . . . . . . . . . . . .
D.1.2.1 Tissue Harvesting . . . . . . . . .
D.1.2.2 Culture . . . . . . . . . . . . . . .
D.1.2.3 Cell Isolation . . . . . . . . . . .
D. 1.2.4 Red/Green Cell Viability Assay . .
D. 1.2.5 Paraformaldehyde/Ethanol Fixation
D. 1.2.6 TUNEL Staining of Fixed Cells . .
D. 1.3 Results and Discussion . . . . . . . . . . . .
D.2 Flow Cytometry of PI stained cells . . . . . . . . . .
D.2.1 Introduction . . . . . . . . . . . . . . . . . .
D.2.2 Materials and Methods . . . . . . . . . . . .
D.2.2.1 Ethanol Fixation of Cells . . . . .
D.2.2.2 Nuclear Content Measurements . .
D.2.2.3 Results and Discussion . . . . . .
D.3 Agarose Gel Electrophoresis of Apoptotic DNA . . .
D.3.1 Introduction . . . . . . . . . . . . . . . . . .
D.3.2 Materials and Methods . . . . . . . . . . . .
D.3.2.1 Harvest, Culture, and Compression
D.3.2.2 DNA Isolation . . . . . . . . . . .
D.3.3 Results and Discussion . . . . . . . . . . . .
85
93
93
93
94
94
97
97
97
103
. . . . . . . . . . . . 103
. . . . . . . . . . . . 103
. . . . . . . . . . . . 104
. . . . . . . . . . . . 104
. . . . . . . . . . . . 105
. . . . . . . . . . . . 105
. . . . . . . . . . . . 105
of Cells . . . . . . . 106
. . . . . . . . . . . . 106
. . . . . . . . . . . . 107
. . . . . . . . . . . . 108
. . . . . . . . . . . . 108
. . . . . . . . . . . . 108
. . . . . . . . . . . . 109
. . . . . . . . . . . . 109
. . . . . . . . . . . . 109
. . . . . . . . . . . . 110
. . . . . . . . . . . . 110
. . . . . . . . . . . . 110
. . . . . . . . . . . . 110
. . . . . . . . . . . . 110
. . . . . . . . . . . . 111
Bibliography 113
7
B.3 Image Processing & Results
8
List of Figures
1-1 Drawing of the Extracellular Matrix of Articular Cartilage
1-2 Diagram of Apoptosis Pathways . . . . . . . . . . . . . .
1-3 Diagram of the Nucleosomes . . . . . . . . . . . . . . . .
1-4 Diagram of Agarose Gel Laddering . . . . . . . . . . . .
2-1 Explant Diagram . . . . . . . . . . . . . . . . . . . . . .
2-2 Injurious Compression Protocol . . . . . . . . . . . . . .
3-1
3-2
3-3
3-4
3-5
3-6
3-7
3-8
3-9
3-10
3-11
3-12
3-13
3-14
3-15
3-16
A-1
A-2
A-3
A-4
A-5
A-6
. . . . . . . . 16
. . . . . . . . 22
. . . . . . . . 29
. . . . . . . . 30
Examples of TUNEL Stained Tissue . . . . . . . . . . . . . . . . . . . . . 42
Apoptosis in Injured Tissue, Dose Response . . . . . . . . . . . . . . . . . 43
Apoptosis in Injured Tissue, Lower Limit . . . . . . . . . . . . . . . . . . 44
Apoptosis in Injured Tissue, Inhibitor Response . . . . . . . . . . . . . . . 45
Examples of Vital Dye Stained Tissue . . . . . . . . . . . . . . . . . . . . 47
Viability in Injured Tissue, Dose Response . . . . . . . . . . . . . . . . . . 48
Viability in Injured Tissue, Kinetics . . . . . . . . . . . . . . . . . . . . . 48
Increases in Tissue Wet Weight . . . . . . . . . . . . . . . . . . . . . . . . 50
Tissue Wet Weight Rates . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Sulfated-GAG Cumulative Release, Time Course . . . . . . . . . . . . . . 52
Sulfated-GAG Release Rate, Time Course . . . . . . . . . . . . . . . . . . 53
Cumulative Sulfated-GAG Loss, Dose Response . . . . . . . . . . . . . . . 54
Cumulative Sulfated-GAG Loss, Apoptosis Inhibitor Effects . . . . . . . . 55
Cumulative Nitric Oxide Release, Dose Response . . . . . . . . . . . . . . 56
Cumulative Nitric Oxide Release, Apoptosis Inhibitor Effects . . . . . . . . 56
Cytokine Induced NO Release . . . . . . . . . . . . . . . . . . . . . . . . 57
Static compression chamber . . . . . . . . . . . . . . . . . . . . . . . . . 66
Incustat - Closeup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
Incustat - Schematic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Incustat Hardware Feedback Diagram . . . . . . . . . . . . . . . . . . . . 69
Incustat Hardware Feedback Schematic . . . . . . . . . . . . . . . . . . . 70
Incustat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
9
34
36
A-7 Strain versus Peak Stress . . . . . . . . . . . . . . . . .7
B-I Spectra of intercalated Ethidium Bromide . . . . . . . . . . . . . . . . . . 76
B-2 Spectra of Fluorescein . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
B-3 Components of the Original Image . . . . . . . . . . . . . . . . . . . . . . 80
B-4 Components of the Transformed Image . . . . . . . . . . . . . . . . . . . 83
B-5 Low-pass Filters for Unsharp Filtering . . . . . . . . . . . . . . . . . . . . 84
B-6 Filtering and Thresholding of Fluorescein Component . . . . . . . . . . . . 86
B-7 Filtering and Thresholding of EtBr Component . . . . . . . . . . . . . . . 87
B-8 Binary EtBr and Fluorescein Components . . . . . . . . . . . . . . . . . . 88
B-9 Erosion and Dilation Filters . . . . . . . . . . . . . . . . . . . . . . . . . . 89
B-10 Enhanced Image . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
B-11 Two Further Examples . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
C-I Equilibrium Moduli for Different Peak Loads . . . . . . . . . . . . . . . . 95
C-2 Normalized Equilibrium Moduli for Different Peak Loads . . . . . . . . . . 96
C-3 Dynamic Stiffness for Different Peak Loads . . . . . . . . . . . . . . . . . 98
C-4 Normalized Confined Dynamic Stiffness for Different Peak Loads . .
C-5 Normalized Unconfined Dynamic Stiffness for Different Peak Loads .
D- 1 Agarose Gel of Apoptotic DNA . . . . . . . . . . . . . . . . . . . .
99
100
112
10
73
List of Tables
3.1 Effects of Apoptosis Inducing Cytokines . . . . . . . . . . . . . . . . . . 46
11
12
Chapter 1
Introduction and Background
Osteoarthritis (OA) is a debilitating disease of articular cartilage that causes pain and de-
creased mobility in millions of people. One form of OA, secondary osteoarthritis, is com-
monly associated with mechanical injury of articulating joints [19, 54], such as car ac-
cidents and falls from height, and is presumably related to degenerative changes in the
cartilage following such trauma. Currently, little is known about what occurs following an
injury, such as the cartilage's response to injury and the cause of further degenerate changes
within the cartilage.
Cellular apoptosis, or programmed cell death, is normally a physiological process
involved in development, immune response, and removal of potentially carcinogenic and
damaged cells. In cartilage, apoptosis occurs during development, as evidenced by the
apoptosis of hyaline cartilage chondrocytes during endochondral ossification [31]. Aber-
rant apoptosis, however, can be pathogenic and has been observed in diseases such as
Alzheimer's [18] and in neuronal cell death following spinal cord injury [22]. Recent find-
ings of apoptotic chondrocytes in human osteoarthritic articular cartilage [59, 6, 42], along
with evidence from an animal model of osteoarthritis (OA) [45] and cartilage wounding
experiments [99, 94], have led to the implication of aberrant apoptosis in the pathogenesis
of OA.
Hypocellularity has been associated with both osteoarthritic tissue and normal carti-
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lage tissue in joints affected with osteoarthritis (OA) [62]. This hypocellularity is believed
to be both a risk factor and a contributor in the disease pathogenesis, and the finding of
markedly increased levels of apoptotic chondrocytes in diseased tissue implicates apopto-
sis mediated cell-loss as a potential cause of OA hypocellularity. The method by which
apoptosis may mediate or cause OA is not currently known, but mechanisms involving cal-
cium precipitation by apoptotic bodies [43], matrix degradation by apoptotic bodies [42],
and the inability of hypocellular tissue to maintain and repair itself [1] have been proposed.
Further evidence of a role for aberrant apoptosis in articular cartilage comes from
correlations of tissue age and the numbers of apoptotic chondrocytes found in normal tis-
sue of adult animals [1]. Since cartilage exhibits an age-related decrease of chondrocytes in
both animal and human tissue [68], there is a strong expectation that this decrease in cel-
lularity arises through apoptosis mediated cell loss. While a correlation between apoptotic
chondrocytes and age in normal human cartilage has not been observed [42], this finding
may be due to the particularly long life span of this particular species.
The cause of chondrocyte apoptosis is not currently known, but in vitro autoradiog-
raphy studies with injuriously compressed cartilage have shown non-viable cell populations
exhibiting condensed nuclei [81] reminiscent of apoptosis. This, coupled with the previous
observations, has led to the hypothesis that injurious mechanical compression of articular
cartilage may be a cause of chondrocytic apoptosis and in turn subsequent OA degenera-
tion. This thesis will examine a model of injuriously compressed articular cartilage, and
the apoptotic cellular response to loading, along with other related markers of tissue degen-
eration.
1.1 Articular Cartilage
Articular cartilage is a dense, highly hydrated, connective tissue that lines the articulating
surfaces of synovial joints. In its mature form, the tissue is aneural, avascular, and alym-
phatic, with the tissue's native cells (chondrocytes) being fed entirely by diffusion [91]
and convection from outside of the tissue. Articular cartilage acts as a flexible, shock-
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absorbing, and wear-resistant surface [74] for the rigid underlying bone, and also provides
for joint lubrication during motion [67].
1.1.1 Molecular Composition
The major constituent of articular cartilage tissue is water, consisting of 70-80% of the
tissue by weight [39, 63]. The remaining components include collagen type II fibrils (50-
65% or tissue dry weight), the cartilage specific proteoglycan "aggrecan" [63], and other
molecular components (Fig: 1-1).
The collagen fibers form a network that provides the tissue with its tensile and sheer
strength. This network is under constant internal tension, arising from the tissue's intrinsic
tendency to swell due to the negatively charged aggrecan molecules. Any decrease in
the tensile strength of the collagen network will manifest itself as an increase in tissue
swelling [64], a hallmark of early-stage osteoarthritic cartilage.
The aggrecan molecules, on the other hand, are responsible for the compressive
stiffness of the tissue [39]. This compressive stiffness arises from the glycosaminoglycan
(GAG) side chains of the aggrecan molecules, which are highly anionic at physiological
conditions. These fixed, negatively charged groups exert mutually repulsive forces against
each other creating a swelling pressure that is counteracted by the collagen fiber network.
1.1.2 Cellular Structure
The remaining volume of the tissue (less than - 10% [41, 90]) consists of a sparse popula-
tion of articular cartilage chondrocytes that is embedded in and protected by the extracel-
lular matrix (ECM) [79]. Due to the avascular nature of cartilage tissue, nutrients for the
cells arise entirely from diffusion, and oxygen tension levels may be as low as 1% [12] (the
normal atmosphere is 24%). Consequently, chondrocyte metabolism occurs primarily by
glycolysis [91]. Convective fluid flow due to joint loading may also significantly affect the
transport of larger protein and soluble factors [29].
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Figure 1-1: A drawing of the extracellular matrix of articular cartilage, showing the colla-
gen network, the proteoglycan "aggrecan", and the chondrocytes embedded in the ECM.
The chondrocytes maintain the ECM's integrity by providing for the synthesis
and secretion of the ECM's constituent molecules, along with their degradation and
turnover [46, 96]. Collagen and aggrecan macromolecules are synthesized inside the cell,
but final assembly of these macromolecules into a functional matrix takes place in the ex-
tracellular space.
1.2 Osteoarthritis
Osteoarthritis (OA) is a common degenerative disease that primarily affects the load-
bearing areas of articular cartilage containing joints. [13]. In OA, fibrillation of the car-
tilage occurs, which is then followed by erosion of the articular surface and mechanical
softening of the cartilage. In severe cases, the underlying bone can be damaged. The main
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consequences of OA are loss of free joint movement, lose of joint stability, and pain. In
severe cases, the disease can be debilitating, requiring total joint replacement.
OA cases can be divided into two major groups, primary and secondary, based upon
the origin of the disease [70]. Primary osteoarthritis develops in joints without any known
cause, and affects predominantly the hands, the spine, and weight-bearing joints such as
the hips and knees. Secondary osteoarthritis is classified under the basis that there is an
identifiable cause for the condition, and may result from events that alter either metabolism
or joint mechanics, such as infection, Wilson's disease, and simple trauma. Secondary
OA is not as strongly correlated with particular joints as primary OA. In either case, once
cartilage damage has begun the end results are frequently indistinguishable.
Lesions associated with OA are usually concentrated in the load-bearing areas of
joints, and increased occurrences of OA are seen when unusual joint loading is present.
These two observations suggest that mechanical factors play an important role in the pro-
gression of OA [49]. Additionally, apoptotic chondrocytes have been observed in human
OA cartilage [59, 6, 42], leading to the speculation that apoptosis may also play a role in
the development of OA.
Severe mechanical loading, such as what occurs in a fall from a height or a traffic
accident (often called impact loading or injurious compression) can directly injure articular
cartilage. Secondary OA is often reported some time after such an event. These observa-
tions have been confirmed by animal studies in which degenerative changes were seen in
the cartilage of knee joints subjected to blunt trauma in vivo [21, 95].
Little, however, is currently known about the ability of articular cartilage to with-
stand and repair itself after impact loads, and a full understanding of the underlying factors
involved are vital for the creation of treatment and prevention schemes. Therefore, the
influences of mechanical loading on the ECM and chondrocyte viability are of significant
interest.
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1.3 Chondrocyte Response to Mechanical Loading
Maintenance of the ECM has been found to be influenced by mechanical loading of the
tissue [40]. This finding has been reported in both in vitro [34, 78, 85] and in vivo [14, 56]
studies.
In brief, static compression of cartilage, compressing cartilage tissue to a fixed
thickness, has been found to cause a compression level dependent decrease in metabolic
activity [78]. Dynamic compression, compressing cartilage tissue to a fixed thickness and
then oscillating 1-10% around that point, has been found to up-regulate metabolic activity
when the applied oscillations were comparable to physiological frequencies [85].
Injurious compression, on the other hand, involves compressing cartilage at rates
and levels far in excess of what is typical in either static or dynamic compression experi-
ments, and is meant to simulate an injury event rather than normal physiological levels of
compression. These compression levels have been previously accomplished with the use of
dropped weight systems [54, 55] and manually operated compression chambers [80], and
have been shown to predispose the ECM to further cell-mediated degradation [80].
Autoradiography studies have shown that following an injurious compression, the
chondrocytes can be grouped into two distinct populations [80]. The first group consists
of cells that are larger than normal and have elevated rates of matrix turnover, which may
indicate a repair response. The second group of cells do not mediate the normal turnover
of matrix molecules and exhibit condensed nuclei and cytoplasm. It is currently believed
that this latter group represents cells that have died through apoptosis.
1.4 Processes for Cell Death
There are two basic processes through which a cell can die. Apoptosis, which is often
referred to as "programmed cell death", and necrosis, which encompasses all other forms
of non-programmed or "accidental cell death".
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1.4.1 Necrosis
When large scale cell death is encountered in a tissue, the cells are usually dying via a
necrotic process. While it is often called "accidental cell death", this phrase only implies
that the death was not part of the normal life cycle of the cell, as necrosis can be caused by
both physiological and non-physiological processes.
The general pattern for necrotic cell death starts with the disruption of the cell mem-
brane, either by a protein insertion into or actual physical disruption of the membrane. A
large Ca++ influx follows, arising from the equalization of the physiologic Ca++ concen-
tration gradient maintained across the cell membrane. The cell then proceeds to consume
all of its energy supplies in a futile attempt to regain homeostasis. One key distinction
between necrotic and apoptotic cell death is this complete consumption of energy. After
running out of energy, the hypertonic cell expands, causing the cell membrane to tear open
and the cell to lyse. Degradation of the cytoskeleton and organelles follows.
To be technically accurate, necrosis refers to the histologically identifiable swelling
that occurs in dead cells, which usually occurs 12 to 24 hours after the cells have passed the
point of no return [61], and is not intended to refer to a mode of cell death. Nevertheless, it
has become common practice to refer to non-apoptotic forms of cell death (more properly
termed oncosis [47]) as necrosis, and this convention will be followed in this text.
1.4.2 Apoptosis
Apoptosis, as opposed to necrosis, does not involve energy depletion, but rather involves the
invocation of a biological pathway that leads to the ordered death and breakup of the cell,
and the advantageous conservation of the energy and nutrients stored therein. Apoptosis
is usually encountered as part of normal physiological homeostasis, being used within the
body to regulate levels of mitosis, to provide for the efficient removal of tissue during
embryogenesis and development (i.e. removal of finger webbing), and to remove cells that
have been irreversibly damaged (i.e. sunburn). Only a small percentage of a cell population
goes through apoptosis at the same time, with larger percentages usually being indicative
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of the cell death arising via necrotic means [61]. Aberrant apoptosis is also thought to be
the causative agent in some diseases, such as the neurodegeneration in Alzheimer's [18]
and in neuronal cell death following spinal cord injury [22].
1.4.2.1 Causative Agents
Apoptosis starts with the cell receiving either an internal or external signal to begin the
apoptotic process. Important internal signals that initiate apoptosis include the actions of
cellular clocks, the detection of deoxyribonucleic acid (DNA) damage, and the infliction
of irreparable internal damage. The term "programmed cell death" actually arose from
observations of cells that were genetically predisposed to dying at fixed times during de-
velopment [57]. The ability of a cell to respond to overwhelming DNA damage by induc-
ing apoptosis, such as when a cell is exposed to ultra-violet light [53, 76], is an important
evolutionary advantage as it reduces the risk of potentially carcinogenic DNA alterations in
multi-cellular organisms. Finally, internal damage to mitochondria, the mitochondria being
important elements of most if not all apoptosis biological pathways (see section: 1.4.2.3),
has the potential to induce apoptotic cell death, allowing the mitochondria to serve as a
form of cellular stress sensor.
External signals come from hormones and cytokines, along with viral, chemical,
and physical agents. Most if not all mammalian cells are dependent on continual signaling
by growth hormones for survival, and will automatically undergo apoptosis in the absence
of these endogenous survival factors [52]. For instance, mesangial cells undergo apoptosis
when IGF- 1 and bFGF are removed from their environment [69]. Chondrocytes undergo
apoptosis when cultured in low cell densities without supplemental growth factors and
anti-oxidants [52], leading to the belief that intercellular signaling between chondrocytes
is an important cue for continued survival of these cells. That cells will undergo apoptosis
when they lose contact with their correct surroundings acts as an important cancer fighting
mechanism in multicellular organisms.
Mammals have the ability to induce particular cells to undergo apoptosis via the use
of apoptosis inducing cytokines, an ability that is important for the action of the mammalian
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immune system [8], where killer T-cells need to selectively deactivate virally infected cells.
These proteins are members of the tumour necrosis factor (TNF) receptor gene superfamily
described further in section: 1.4.2.2. The most two well known and understood are tumor
necrosis factor receptor 1 (TNFR1, also called p55 or CD120a) and CD95 (also known as
Apo- 1 or Fas). Activation of a TNF family receptor (such as CD95) by the appropriate TNF
family ligand (such as CD95L) will induce the cell to undergo apoptosis. A subpopulation
of cells in articular cartilage have been found to express CD95 and can be induced to
undergo apoptosis via an antibody to the receptor [44].
Non-physiological external agents include aberrant disease processes and the ac-
tion of drugs. The camptothecin topoisomerase I inhibitor family of drugs is used in
chemotherapy as they induce apoptosis in dividing cells [77]. Camptothecin's inhibition
of topoisomerase I prevents the enzyme from fulfilling its normal role of altering DNA
topology, resulting in DNA damage during replication and apoptosis. Beta-amyloid pep-
tides in Alzheimer's are neurotoxic and induce apoptotic cell death of the neurons in the
brain [18].
Finally, mechanical injury of tissue has also been found to lead to the induction
of apoptosis. Overstretching of muscle tissue has been shown to induce myocytic apop-
tosis [15]. The creation of lesions in chick hyaline cartilage has been shown to induce
apoptosis in nearby cells [99]. The bovine articular cartilage injurious compression model
developed in this thesis is also an example of mechanically induced apoptosis (see sec-
tion: 3.1.1.1). The transduction mechanism that regulates mechanically induced apoptosis
is currently unknown.
1.4.2.2 Signal Transduction
Following the initial signaling event, the cell may proceed through a number of different
biochemical pathways. A schematic of some of the more important and common biological
pathways and proteins involved in the process of apoptosis are shown in Figure: 1-2. The
more important initiators of apoptosis are shown, including ligand binding to the CD95 and
TNFR1 receptors, and direct action on the mitochondria.
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Figure 1-2: Flow diagram of biological pathways commonly associated with the induction
and process of apoptosis.
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The receptors responsible for mediating cytokine induced apoptosis belong to the
TNF receptor gene superfamily and have similar, cysteine-rich extracellular domains [88].
Additionally, these receptors have a homologous intracellular sequence called the "death
domain" (DD) [92]. Examples of death receptors are CD95, TNFR1, DR3 (also called
Apo3 and Wsll), DR4 or DR5, DcR2, and DcR1, with CD95 and TNFR1 being the best
known examples.
1.4.2.2.1 CD95 The CD95 receptor is perhaps the best understood of the cytokine apop-
tosis signaling pathways. CD95 has three main roles under physiological conditions. It is
used in the killing of activated T cells at the completion of an immune response, the killing
of virus-infected and cancer cells by cytotoxic T cells and natural killer cells, and the killing
of inflammatory cells at immune-privileged sites such as the eye [3].
Signaling with CD95 begins with binding of the ligand for CD95, CD95L, which
is a homotrimeric molecule like all other ligands in the TNF family members. Since death
domains (DD) tend to associate with one another, ligation of CD95L to 3 individual CD95's
leads to the intracellular aggregation of the three DD's on the CD95 proteins [50]. The
adapter protein FADD (for Fas-associated death domain, also called Mortl) binds to the
aggregated death domains of CD95 with its own death domain [17].
The next step in the CD95 transduction pathway involves the clustering of
procaspase-8 proteins (the zymogen form of caspase-8, which is also called FLICE or
MACH), which are attracted by procaspase-8's "death effector domain"(DED) to an anal-
ogous domain on FADD [9, 72]. This aggregation of procaspase-8 creates a high local
concentration of the zymogen, allowing the small proteolytic activity inherent in the pro-
tein to induce proteolytic activation through intermolecular self-cleavage [73]. The role of
caspase-8 in the inducement of apoptosis is covered further in section: 1.4.2.4.
1.4.2.2.2 TNF TNF is the other well known apoptosis inducing cytokine pathway and
is the namesake for the TNF gene super family. The ligand (called TNF or alternatively
TNF-a) is produced mainly by activated macrophages and T cells in response to infection.
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However, there is some evidence that the TNF ligand may play a role in inducing focal
losses of cartilage in OA [101] due to enhanced expression of the TNF-a receptor p55 in
OA chondrocytes [51].
While the receptor for TNF, TNFR1, is expressed in all cell types [93], ligation of
TNF to TNFR1 rarely induces apoptosis unless protein synthesis is blocked. This is the
opposite of CD95, which is not expressed in all cell types but generally induces apopto-
sis upon ligation of CD95L. The suppressive proteins involved in the TNF pathway are
probably controlled through the NF-rB and JNK/AP-1 pathways [5].
When the TNF pathway does induce apoptosis, it proceeds via a mechanism analo-
gous to that of CD95. The TNF ligand trimerizes TNFR1 [88], which leads to aggregation
of FADD, clustering of procaspase-8, and finally self-activation. The role of caspase-8 in
the inducement of apoptosis is covered further in section: 1.4.2.4.
1.4.2.2.3 Other Signaling Proteins There are other signaling proteins in the TNF gene
super family that can induce apoptosis. Apo2 ligand (Apo2L, or TRAIL) is constitutively
expressed in many tissues [104], binds to either DR4 or DR5 to induce apoptosis, and
proceeds via a FADD independent pathway [107]. As DR4 and DR5 are expressed in
many tissue types, there is most likely a mechanism that protects cells from induction of
apoptosis in the Apo2L pathway.
The Apo3 signalling pathway has overlapping functions with TNF, but is found
in a greater variety of tissues [65]. Apo3 ligand (Apo3L, or TWEAK) is constitutively
expressed in many tissues [16], while its receptor, Apo3 (also DR3, WSL-1, TRAMP and
LARD), is expressed mainly in the spleen, thymus, and peripheral blood.
1.4.2.3 Mitochondrial Roles
The mitochondria play both central roles in most of the apoptosis pathways and have the
ability to induce apoptosis on their own, in effect serving as both stress sensors and exe-
cutioners. This role makes sense from an evolutionary standpoint, as a cell without mito-
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chondria, and therefore without a key anti-cancer weapon, is a cell that cannot metabolize
efficiently and is not a cancer threat to begin with [35].
The mitochondrial role in apoptosis depends on the release of the electron-transport
chain molecule cytochrome c (cyto c) and/or the protein apoptosis-inducing factor (AIF)
from within the mitochondria. This release can be caused by a variety of factors includ-
ing caspase activity, oxidants, the protein Bax, and direct mitochondria membrane dam-
age [35].
Following release, the cytostolic cyto c conjugates with Apaf-1, and the com-
plex then conjugates with procaspase-9 [60], causing self-activation of procaspase-9 into
caspase-9 in a manner analogous to the self-activation of caspase-8 in the CD95 pathway.
The activated caspase-9 then cleaves procaspase-3 into its activated form, caspase-3. The
continued role of activated caspase-3 in apoptosis is covered further in section: 1.4.2.4.
The release of cyto c is inhibited by Bcl-2 [58]. Some pro-apoptotic proteins, notably Bax,
can induce mitochondrial damage, cyto c release and resultant cell death even when cas-
pases are inactivated [106]. This demonstrates that release of cyto c from the mitochondria
commits the cell to death, whether it be by a fast apoptotic death via Apaf- 1 and resultant
caspase activation, or a slow, necrotic death due to the collapse of the electron transport
chain and energy starvation.
The release of AIF, which is currently thought to be a caspase, by the mitochon-
dria causes the activation of caspase-3 from procaspase-3. Following activation, caspase-3
continues on as described in section: 1.4.2.4.
1.4.2.4 Caspases
All of the biological pathways through which apoptosis is induced eventually proceed via
the caspase proteins (Cysteinyl-aspartic acid proteases, also called interleukin converting
enzymes, or ICE's), which appear to be the point of no return in the process [4]. The
caspases are a highly conserved set of proteins specific to the apoptosis process and are
constitutively expressed in most if not all mammalian cells [102], even "life-time cells"
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such as neurons.
Caspases share similarities in amino acid sequence, structure, and most importantly,
substrate specificity [75]. Caspases are among the most specific of proteases, having an
absolute requirement for cleavage after aspartic acid and recognition of an at least four
amino acid sequences NH2-terminal to the cleavage site. This specificity is consistent with
observations that apoptosis does not lead to indiscriminate protein digestion.
Caspases are created as pro-enzymes, or zymogens, with extremely low levels of
activity and consisting of three domains, the pro-domain, the large-domain, and the small-
domain. The low catalytic activity allows large quantities of the caspase precursors to be
built up and stored within the cell. Since proteolysis is an irreversible process, activation
of caspases by cleavage allows the cell's commitment to apoptosis to be an irreversible
process.
Activation of a caspase requires cleavage between the prodomain and the other
two domains at a site whose sequence is specifically recognized by the catalytic site of
caspases. A structural change can then occur whereby the small and large domains form
a heterodimer. Two separate heterodimers then associate to form a tetramer, with two
independent catalytic sites.
There are two basic processes by which the zymogen pro-caspases can be cleaved
into their active forms. The simplest is proteolysis of the pro-caspase by a previously
activated caspase. Since all activated caspases can cleave and activate all pro-caspases,
a "caspase cascade" can occur whereby a small, threshold level apoptotic signal can be
amplified and lead to the activation of all caspases and resultant apoptosis.
The second method of activation is by induced proximity and appears to be the
common method for the initial transduction of the apoptosis signal to the caspases. In in-
duced proximity, pro-caspases are aggregated, and due to the high local concentration the
inherent low protease activity of the pro-caspase zymogens is sufficient to drive intermolec-
ular proteolytic activation. This activation method was first observed for caspase-8 in the
CD95 pathway [73] and is thought to be the method whereby cyto c bound Apaf- 1 is able
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to activate caspase-9 [89].
Only a few of the roles that the different caspases play in effecting cell death are
known. Known roles include endonuclease activation, destruction of the nuclear lamina,
cleavage of proteins important in cytoskeleton regulation, and shutdown of DNA repair,
mRNA splicing, and DNA replication.
Endonuclease activation is partially accomplished by cleavage of the caspase-
activated deoxyribonuclease (CAD) inhibitor (ICAD, or DFF45) by caspase-3 from the
CAD-ICAD complex [86]. This leaves the endonuclease CAD free to act upon the chro-
mosomal DNA and helps lead to the internucleosomal cleavage discussed further in
section: 1.4.2.6.2. Caspase activation also leads to the destruction of the nuclear lam-
ina [82], the rigid structure composed of intermediate filaments underlying the nuclear
membrane, causing the condensation of the chromatin. Furthermore, caspase cleavage of
several proteins important in the regulation of the cytoskeleton leads to the reorganization
of cell structures. Proteins effected include gelsolin, focal adhesion kinase (FAK), and
cleavage induced activation of p21-activated kinase 2 (PAK2) [84].
1.4.2.5 Other Apoptosis Associated Proteins
There are many other proteins involved in the process of apoptosis. Some of the more
important ones not covered so far are Bcl-2, Bax, p53, and Parp.
Bcl-2 is the prototype for a large family of proteins that can either prevent or pro-
mote apoptosis. Bcl-2 is an important anti-apoptotic protein that is localized near the mito-
chondria membrane. How it performs its anti-apoptotic role is unclear, but Bcl-2 is thought
to prevent the release of AIF and cytochrome C from the mitochondria. In chondrocytes,
Bcl-2 has been implicated in regulating the apoptotic response of chondrocytes subjected
to serum-withdrawal or retinoic acid treatment [26]. Additionally, increased expression of
Bcl-2 has been reported in chondrocytes near defects in OA tissue [23].
Bax is a pro-apoptotic member of the Bcl-2 family that induces apoptosis by acting
on the mitochondrial membrane. Levels of Bax were unchanged in response to serum-
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withdrawal or retinoic acid treatment of chondrocytes [26]. P53 blocks the process of DNA
repair, playing a critical role in the induction of apoptosis due to chromosomal damage.
Finally, Parp, normally responsible for DNA repair, is cleaved into an inactive form by the
caspases.
1.4.2.6 Cellular Effects
1.4.2.6.1 Phosphatidylserine Translocation One of the earliest detectable changes in
apoptotic cells is the translocation of phosphatidylserine (PS) to the outer leaflet of the cell
membrane [98]. Under normal physiological conditions, the enzyme aminophospholipid
translocase maintains the asymmetrical distribution of PS toward the inner leaflet of the
plasma membrane. Shortly after the inducement of apoptosis, translocase is inactivated and
the distribution of PS between the outer and inner leaflet becomes symmetric by nonspecific
flip-flop of phospholipids between the leaflets [11] and/or the activity of a hypothesized
enzyme "scramblase" [97] (depicted in Figure: 1-2). The exposure of PS serves as a marker
for phagocytosis allowing a non-inflammatory response by macrophages [24].
Since this translocation occurs in apoptosis without the accompanied disruption of
the plasma membrane found in necrosis, it can be used as a method for the distinguishment
of necrotic, apoptotic, and viable cells. Annexin V staining makes use of FITC labelled
Annexin V, a Ca++ dependent phospholipid-binding protein that binds to PS, to detect the
presence of PS on the outer leaflet [109].
1.4.2.6.2 Chromosomal DNA Cleavage Another detectable change that is commonly
used for assaying apoptosis is internucleosomal cleavage of the chromosomal DNA by
endonucleases. Although the mechanism of this cleavage is not completely understood,
caspase activated endonucleases such as CAD certainly play a role in the process along
with Ca++ and Mg++ dependent nucleases such as DNAse I.
The actual degradation of the chromosomal DNA begins with it breaking up into
large, ~300 kbp fragments, which are then further degraded into -50 kbp fragments. Both
the -300 kbp and -50 kbp fragments can be detected with the use of pulsed field gel elec-
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Figure 1-3: A diagram of the Nucleosomes showing typical DNA lengths.
trophoresis [100]. The chromosomal DNA in most cells is then further cut into < 40 kbp
fragments by random endonuclease activity, from which small oligonucleosome fragments
with lengths that are multiples of -- 185 bp are released. It is these oligonucleosomes that
allow for the classic dna laddering shown on agarose gels [32].
That the oligonucleosomes come in lengths that are multiples of ~ 185 bp arise
from the physical structure of chromosomal DNA. When DNA is not being transcribed or
replicated, it is wrapped in structures called nucleosomes, which are composed of -140 bp
of DNA wrapped around 8 histone proteins (two each of H2A, H2B, H3, and H4) with
a HI histone protein locking the DNA into the assembly (Fig: 1-3). Since the DNA is
not released from the nucleosomes during apoptosis, cleavage must occur in the linker
DNA region between the nucleosomes [105], which leaves fragments that are multiples of
~185 bp (Fig: 1-4).
The chromosomal DNA cleavage leaves many cut edges of DNA, which lend them-
selves to apoptosis identification by the nick-end labeling methods. Both TUNEL (terminal
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Figure 1-4: A diagram of the endonuclease activity that leads to the characteristic laddering
pattern of apoptotic DNA on an agarose gel.
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deoxynucleotidy transferase mediated UTP nick end labeling) [30] and ISEL (in situ end
labeling) [103] work by incorporating artificial nucleotides into the DNA where it is cut,
allowing identification of apoptosis even when only large (~,300 kbp) fragments are avail-
able. The only difference between the two methods is the enzyme used for the artificial
nucleotide incorporation. ISEL uses DNA Polymerase I (or the Klenow fragment of DNA
Polymerase I), which can label 3' recessed ends of the cut DNA. TUNEL uses of terminal
deoxynucleotidy transferase (TDT, or terminal transferase), which can label 3' recessed,
5' recessed, and blunt ends of the cut DNA. This ambivalence to the shape of the cut ends
makes TUNEL more sensitive [71] and the more commonly used of the two assays.
The artificial nucleotides used in the nick-end labeling methods tend to either be
fluorescein or digoxigenin conjugated. In the case of digoxignenin, an anti-digoxigenin
antibody that is either conjugated to fluorescein or peroxidase is then used. In any case,
since viable cells do not have large numbers of DNA ends, they will show very little signal.
Necrotic cells generally do have large numbers of DNA ends due to degraded chromosomal
DNA, but since the nuclear membrane is ruptured, the DNA will diffuse and a concentrated
signal will not be displayed. Only in the case of apoptotic cells will a concentrated and
strong signal be seen.
1.4.2.6.3 Apoptotic Body Formation Following the fragmentation of the cell's DNA,
the cell begins to convolute and form buds. These buds eventually separate and the cell
disintegrates. These separated buds are called apoptotic bodies and are generally phago-
cytosed by neighboring cells and macrophages [47]. In cartilage, no phagocytic cells exist
and the apoptotic bodies are likely to remain in the cartilage extracellular matrix. Most
proteins, nucleotides, and other important molecules are recovered by these phagocytosing
cells. While the cell membrane and other membranes are not compromised during these
processes, the cell membrane does lose most of its function and its permeability is altered.
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1.5 Thesis Objectives
In an effort to better understand the conditions under which apoptosis occurs in articu-
lar cartilage and the role apoptosis may play in both normal cartilage function and os-
teoarthritic degeneration, this thesis focuses on an in vitro model system for apoptosis
induced by injurious mechanical compression in articular cartilage. The creation and un-
derstanding of a well-defined and repeatable model for the generation of apoptosis in artic-
ular cartilage is a necessary prerequisite for quantitative studies. Cartilage specimens are
subjected to graded levels of mechanical compression, and the TUNEL method is used to
assess the extent of chondrocyte apoptosis. These results are compared to additional met-
rics of tissue injury including cell viability and biochemical changes. Threshold levels of
mechanical stress, strain, and strain rate that result in biochemical and apoptotic changes
are identified and compared.
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Chapter 2
Materials and Methods
2.1 Materials
Dulbecco's phosphate buffered saline (PBS), gentamicin, non-essential amino acid solu-
tion, HEPES, and Dulbecco's modified Eagle's medium (DMEM) were purchased from
Gibco, Grand Island, NY L-proline, shark chondroitin sulfate, ascorbic acid, sulfanil-
amide, napthylethylenediamine dihydrochloride, ethidium bromide, and sodium nitrite
were purchased from Sigma, St. Louis, MO. Ethanol was from Pharmco, Brookfiled, CT.
Dimethylmethylene blue and fluorescein diacetate were from Polysciences, Warrington,
PA. Dimethyl sulfoxide (DMSO) was from from Mallinckrodt, Paris, KY. IL-l# was pro-
vided by MERCK Research Laboratories. TNF-a was obtained from R & D systems, Min-
neapolis, MN. Z-VAD-fmk and SB-279885 was provided courtesy of Dr. Michael Lark
and associates at SmithKline Beecham, King of Prussia, PA.
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Figure 2-1: The general procedure used for the explanting of cartilage disks is shown. Full-
thickness cores are cored out of the femoropatellar groove. Two 1 mm thick slices are then
taken, and four 3 mm diameter by 1 mm thick cartilage disks are obtained from each slice.
2.2 Methods
2.2.1 Tissue Protocols
2.2.1.1 Tissue Harvesting
Articular cartilage tissue was harvested from the femoropatellar groove as previously de-
scribed [85]. Briefly, 1 mm thick by 3 mm diameter cartilage disks (~8 mg wet weight at
time of explant) were explanted from the femoropatellar grooves of 1-2 week old calves
using a 3/8 inch coring bit mounted on a drill press, a sledge microtome (Model 860, Amer-
ican Optical, Buffalo, NY) and a 3 mm dermal punch (Miltex Instruments, Lake Success,
NY) (Fig: 2-1). The joint surface and explanted tissue was kept moist at all times by im-
mersing in or irrigating with a phosphate-buffer saline (PBS) solution containing 50 pg/ml
gentamicin.
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2.2.1.2 Feeding
During the course of an experiment, the cartilage tissue disks were maintained in low-
glucose, 10% serum-supplemented DMEM with 10 mM HEPES buffer, 110 mg/ml sodium
pyruvate, 0.1 mM non-essential amino acids, 0.4 mM proline, 0.1 mM ascorbate acid
(20 pg/ml) and gentamicin (50 pg/ml, reduced to 25 pg/ml after the first day). During
experiments involving cytokines, high-glucose serum-free DMEM was used to avoid any
ambiguities arising from growth factors and other proteins inherent in the serum. In exper-
iments involving apoptosis inhibitors, a 10 mM stock solution was made by dissolving the
inhibitors in appropriate volumes of 100% DMSO. The stock solutions were then used in
preparation of the medium, and an equal volume of 100% DMSO was added to the control
medium.
2.2.2 Injurious Compression Protocols
Injurious Compression
Following 1-2 days in culture, between 3 and 10 disks of tissue to be loaded were placed
inside of a 12 well polysulfone compression chamber (Fig: A-1) with 0.5 ml media per well.
Inside the compression chamber, the disks were sandwiched between two impermeable
platens, allowing uniaxial, radially unconfined compression to be applied by loading of
the top of the compression chamber. The compression chamber was then placed inside
a custom built incubator housed compression apparatus [28] (incustat, appendix: A) for
the application of the injurious compression protocol (calibration procedure is described in
section A.5). The number of disks in the chamber was picked so that the peak load attained
during the compressive phase of loading would not exceed the incustat server motor's limit
of around 45 kg.
The disks in the chamber were then subjected to an injurious compression protocol
(Fig: 2-2). The protocol consisted of:
1. A quick compression to 50-70% of cut thickness (30%-50% strain) at a strain rate of
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Figure 2-2: Output from a typical injurious compression protocol is shown. Peak stress
generated was ~ 10 MPa for this example. Displacement corresponds to the expected
thickness of the cartilage disk.
100% of the disks thickness per second (1000 pm/s)
2. Maintaining this strain level for 5 minutes
3. Releasing the compression for 25 minutes
4. And repeating this on/off compression cycle for a total of 6 times
Load measurements were recorded during all experiments, and the peak stresses
produced during the compression (between 4 and 25 MPa depending on the chosen strain
level) were used for comparisons between different experiments. (Compressive strains
were not used to compare these experiments due to problems with machine compliance
and displacement calibration, as discussed in section: A.5.
Anatomically matched free-swelling disks served as controls and were maintained
in an unloaded compression chamber alongside the loaded chamber during the course of
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the experiment. Media and handling conditions were identical to that of the compressed
disks.
Following the compression, the disks were maintained in media for zero to six days,
depending on the experiment. Conditioned media samples were stored at -20' C for later
analysis (described in section: 2.2.3).
2.2.3 Biochemical Assays
2.2.3.1 Wet Weight Measurements
Wet weights of cultured tissue were taken by patting each disk dry with sterile gauze,
placing it inside of a pre-weighed sterile vial, and differentially weighing the disk (AE 163
Balance, Mettler Instrument Corp, Hightstown, NJ).
2.2.3.2 Sulfated GAG Assay
Conditioned media was assayed for sulfated glycosaminoglycan (sGAG) released into the
media using the dimethylmethylene blue (DMMB) dye method [25] with chondroitin sul-
fate from shark cartilage used as the standard. Briefly, 20 pl media was mixed with 200 Pl
DMMB dye, 20 pl of 70% ethanol was added to remove bubbles, and the absorbance at
520 nm was measured using a microplate reader (Vmax microplate reader, Molecular De-
vices, Menlo Park, CA)
2.2.3.3 NO Assay
Nitric oxide levels in the conditioned media were assessed by placing media samples
through the Griess reaction [36, 37, 38] and measuring the absorbance at 560 nm, with
the use of sodium nitrite for standards. Briefly, media was spun at 16,000 g for 1 minute
to remove any debris. 100 pl of the media supernatant were then mixed with 50 p1 1%
sulfanilamide in 5% H3 PO4 and 50 pl 0.1% naphthylethylenediamine dihydrochloride,
with 20pl of 70% ethanol added to remove bubbles, incubated at room temperature for
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20 minutes, and measured for optical absorbance at 560 nm in a microplate reader (Vmax
microplate reader, Molecular Devices, Menlo Park, CA).
2.2.3.4 Apoptosis Assays
Levels of apoptosis were measured in cartilage tissue through a collaborative effort with
Smith-Kline Beecham (SKB). Injurious compressed disks were flash frozen by direct im-
mersion in liquid N2 , stored at -80 'C prior to shipment, and shipped on dry ice to SKB
for further processing.
At SKB, each disk was serially cryostat sectioned into semi-thin (8 pm) sections
(~125 sections/disk) and immobilized on glass slides. The sections were then air-dried,
fixed, and stained for the presence of apoptotic nuclei following the manufacturer's pro-
tocol (ApopTag peroxidase in situ apoptosis detection kit, Oncor, Gaithersburg, MD). The
peroxidase enzyme label used yielded an insoluble brown stain in positive nuclei. All ~125
sections/disk were scored blind for the presence of apoptotic nuclei. Sections with posi-
tive staining nuclei at their periphery were considered negative (score of -1, 0, or 1), as
these apoptotic cells were artifacts of the cutting process [99]. Sections considered pos-
itive had apoptotic nuclei away from their edges and were scored according to whether
there were small (score of 2) or large numbers (score of 3) of positive nuclei. The final
number reported for each disk was the percentage of positive sections (score 2 or 3) to the
total number of sections from the disk. In another series of experiments, the percentage of
apoptotic cells was also assessed. This was done by counting and averaging positive and
negative staining cells in the central region on 3-5 separate sections (300-500 cells total) of
a given disk.
2.2.3.5 Red/Green Fluorescence Cell Viability Assay
Viability in cartilage tissue disks was assessed with the vital dyes ethidium bromide (EtBr)
and fluorescein diacetate (FDA) [2, 87]. Each disk to be assayed was sliced completely into
-200 tm sections with a scalpel blade and then immersed into an 18 pM EtBr (25 pg/ml),
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250 pM FDA (10 pg/ml) in PBS solution. (For an explanation of the theory behind the
assay, please see section: B. 1) The tissue sections were immediately examined under fluo-
rescence microscopy (Nikon Diaphot, Japan) using a 450-490 nm excitation filter, a 510 nm
dichroic mirror, and a 520 nm barrier filter (B-2A filter set). Viability was then determined
for a random location near the center of 3-4 sections, and these viability numbers were
averaged together to form a viability score for the entire disk.
2.3 Statistics
Control and experimental groups were compared using Student's paired t test when appro-
priate and Student's t test assuming equal variances otherwise, with significance at the level
p < 0.05.
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Chapter 3
Results of Injurious Compression on
Articular Cartilage
3.1 Effects on Cellular Viability
3.1.1 Apoptotic Response
3.1.1.1 Induction of Apoptosis
Injurious mechanical loading of bovine articular cartilage disks resulted in an increase in
the number of cells staining positive for apoptosis via the TUNEL method that was dose-
dependent on the applied peak stress (Figs: 3-1 & 3-2). This increase was significant at
10 and 20 MPa, with the number of cells staining positive for apoptosis nearly 50% for
the 20 MPa condition. Loading with even a relatively mild injurious compression protocol
(~4.5 MPa) resulted in a significant increase in the number of sections judged positive for
apoptosis (score of 2 or 3) for loaded cartilage tissue versus free swelling controls (Fig: 3-
3).
In both the loaded disks and the unloaded control disks, numerous cells at the cut-
edge stained positively for apoptosis, as has been reported previously for the cutting of
articular cartilage [99]. In contrast, there was a significant increase in apoptotic nuclei in
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Figure 3-1:
Examples of cartilage tissue stained with TUNEL. A) Tissue loaded with a peak stress of
-6 MPa showing scattered positive TUNEL staining. B) Tissue loaded with a peak stress
of ~21 MPa showing a large number of positive staining cells.
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Figure 3-2: Apoptosis was induced in cartilage tissue by application of different levels of
injurious compression. Cartilage explant disks were subjected to peak compressive stress
of 0 (control), 6, 10, and 20 MPa, subsequently incubated for 4 days, and then analyzed
for apoptotic nuclei with the TUNEL assay. Data are mean±SEM; * indicates p < 0.05 by
paired t test.
43
80 
2 *
0 .
00
'-W
0
6 0-
CotoC~.o~
0
0
.2 20-
0
Control -4.5 MPa
Figure 3-3: Apoptosis was induced in tissue with a relatively mild injury (-4.5 MPa)
protocol. Results are shown as the precentage of sections considered positive for apoptosis
(score of 2 or higher). Data are meaniSEM; * indicates p < 0.05 by paired t-test.
the central region of the loaded cartilage disks (e.g., Fig: 3-3).
Although the TUNEL staining portion of a time course study had not yet been
completed at the time of this writing, experiments in other labs have shown that apoptotic
chondrocytes in articular cartilage remain stainable via TUNEL for apoptosis for at least 20
days in explant culture [94]. An experimental wounding model in embryonic chick hyaline
cartilage has also shown that an apoptotic response can be detected after only 10-20 minutes
post-wounding and that the apoptotic effect of the wounding reached a maximum at two
days post-injury [99].
3.1.1.2 Effects of Apoptosis Inhibitors
Preliminary data from the TUNEL staining of cartilage tissue that had been given a
~20 MPa peak stress injury and had been maintained in media containing the general
caspase inhibitor Z-VAD-fmk (Z-Val-Ala-Asp Fluoromethyl Ketone) before, during, and
for the four days after injury before being frozen is shown in Figure: 3-4. The SmithKline
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Figure 3-4: Tissue was given a ~20 MPa peak stress injury, incubated for four days with or
without the use of inhibitors, and then stained for apoptotic cells using the TUNEL assay.
50 pM Z indicates 50 pM Z-VAD-fmk, 25 pM Z indicates 25 pM Z-VAD-fmk.
Beecham inhibitor SB-279885 at a concentration of 25 pM had also been used, but data
from that condition had not yet been generated at the time of this writing. There were no
apparent differences between the different conditions, but a conclusive answer cannot be
given due to the small sample size (n=2).
3.1.1.3 Effects of Apoptosis Inducing Cytokines
The effects of cytokines that are known to induce apoptosis in certain cell types were ex-
amined in order to verify the accuracy of the apoptosis assay. The two cytokines used were
TNF-ao and IL-l#. TNF-a at 100 pmol/ml produced an apoptotic signal, as expected, that
was slightly higher than that seen in injuriously compressed samples (Table: 3.1). No apop-
tosis was seen with 100 pmole/ml of IL-l#, which is consistent with previously published
reports that examined the effects of IL- 1# on chondrocytes [7]. Only a single section was
looked at from each disk in this study, so the results were non-quantitative and should be
regarded with caution.
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Group Result of TUNEL
Control (no cytokine) Some Postive Staining
IL-l (100 ng/ml) No Staining
TNF-a (100 ng/ml) Some Positive Staining
IL-1# (100 ng/ml) + TNF-a (100 ng/ml) No Staining
Table 3.1: Effects of Apoptosis Inducing Cytokines
3.1.2 General Viability Changes
3.1.2.1 Results of Cell Viability Assay
Injurious mechanical compression of cartilage disks resulted in marked decreases in cell
viability in the centers of the disks, as measured by the vital dyes ethidium bromide and
fluorescein diacetate 6 days post-compression (Figs: 3-5 & 3-6). This decrease in cell
viability was strongly dependent on the peak stresses generated, with significant changes
between loaded and control disks beginning around 10 MPa peak compression stress and a
~25% reduction in viability being seen around 20 MPa. For all loaded disks, the viability
was best in the center, were the viability measurements were taken, and worsened traveling
toward the sides of the disk. Control and loaded disks always displayed 2-6 cell layers of
dead cells along all of the edges that were artifacts of the cutting process. Fracturing of
the cartilage tissue was not seen until the disks were compressed above a peak stress of
~15 MPa and was usually associated with extremely low (5-10%) viability.
A time course study done with an 18-20 MPa peak stress injurious compression
applied to the disks showed that the change in vital dye staining was apparent even di-
rectly after the completion (3 hrs after initiation) of the injurious compression protocol and
remained constant at -30% for the following two days (Fig: 3-7).
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Figure 3-5: Examples of cartilage tissue sections stained with ethidium bromide and fluo-
rescein diacetate. A) Section of an unloaded control disk showing cutting artifacts along
the edges. B) Higher magnification of an unloaded control disk, again showing the cutting
artifacts. C) Section of a loaded explant disk subjected to 17 MPa peak stress exhibiting
~50% viability and cutting artifacts along the edges. D) Higher magnification of a differ-
ent loaded explant disk compressed with -17 MPa peak stress. The tissue exhibits deep
fissures and extremely low viability. Bar indicates 100 pm.
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Figure 3-6: Changes in cell viability were measured using the red/green assay 6 days af-
ter injurious compression to peak streses of 0 (control), 6, 10, and 20 MPa. Data are
mean±SEM; * indicates p < 0.05 by paired t-test.
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Figure 3-7: Changes in cell viability were measured using the
2 days after a relatively high loading condition to a peak stress
meantSEM; * indicates p < 0.05 paired t-test.
red/green assay 0,1, and
of 18-21 MPa. Data are
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3.2 Effects on Tissue Properties
3.2.1 Biochemical Changes
3.2.1.1 Wet Weight
Tissue wet weights were measured daily for 6 days following injury at several different
injurious compression levels (Fig: 3-8) and showed a clear dose-dependent response. At
the lower compression levels (7 and 8.5 MPa peak stress) no significant changes were seen
in the wet weights of loaded tissue compared to that of free swelling controls. At 12 MPa,
the loaded tissue showed a significant increase in wet weight compared to control, and by
13 MPa this difference between control and loaded wet weights was even more apparent.
The 17 MPa condition clearly showed the effect of the collagen network damage and rapid
swelling and was the only condition in which the loading was severe enough to produce
a significant increase in tissue swelling even directly after the injurious compression. An
analysis of the rate of tissue swelling (Fig: 3-9) showed that any increase in wet weight
over that of controls occured within one day of compression.
3.2.1.2 Sulfated GAG Loss
The cumulative sGAG release from injured disks paralleled changes in the tissue wet
weights (Fig: 3-10), also showing a clear dose response. At the lower injury levels (7-
8.5 MPa), significant differences in sGAG release were not generally seen. At the 8.5 MPa
condition, the cumulative sGAG release was higher directly after compression, but fell back
to normal levels immediately afterwards. Around 12 MPa, a small yet significant change
from control values was apparent. By 13 MPa, a strong and significant difference in sGAG
loss arose, with the cumulative loss nearly 75% greater than that of the free-swelling con-
trols for the 13 and 17 MPa loading conditions by day 6. A look at the sGAG release
rates (Fig: 3-11) shows that the rates were sharply increased during the compression and
remained significantly elevated for 2-5 days before returning back to control values.
In a separate series of experiments, the cumulated sGAG released by day four was
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Figure 3-8: The wet weights of injured cartilage disks are shown along with their matched
controls for different peak stress loading conditions. Tissue wet weights were recorded
immediately before and immediately after compression to 7, 8.5, 12, 13, and 17 MPa peak
stress and every day afterwards for 6 days Data are normalized to the measured wet weight
before compression;meantSEM, n=6; * indicates p < 0.05 by paired t test.
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Figure 3-9: The rate of increase in wet weight of injured cartilage disks, shown along with
their matched controls for different peak stress loading conditions. The weights are normal-
ized to the weight of the tissue immediately prior to compression. Data are meaniSEM; *
indicates p < 0.05 paired t-test.
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Figure 3-10: The cumulative release of sulfated-GAG's to the media are shown for injured
cartilage disks along with their matched controls for different peak stress loading condi-
tions. Cartilage explants were subjected to peak stresses of 7, 8.5, 12, 13, and 17 MPa,
with free-swelling anatomically matched tissue serving as control. Conditioned media was
stored directly after compression and every day thereafter, and analyzed for sGAG. Each
data point represents the total GAG lost to the medium by that day. The results are normal-
ized to the tissue's wet weight at time 0. Data are mean±SEM, n=6; * indicates p < 0.05
by paired t test.
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Figure 3-11: The release rate of sulfated-GAG's to the media are shown for injured cartilage
disks along with their matched controls for different peak stress loading conditions. Each
data point represents the GAG lost to the medium at that time point divided by the amount
of time the tissue was in that particular medium. The values are normalized to the tissue's
wet weight at time 0. Data are mean±SEM; * indicates p < 0.05 by paired t-test.
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Figure 3-12: The total sGAG lost to the media by day 4 following injurious compression
on day 0 is shown for different levels of injurious compression. Data are mean±SEM; *
indicates p < 0.05 by paired t-test.
measured using disks subjected to 0, 6, 10, and 20 MPa peak stress (Fig: 3-12). A small but
significant increase in cumulative sGAG loss at four days was observed in both the 6 MPa
and 10 MPa peak stress loading conditions. Not only did all three stress values show
significantly increased sGAG loss compared to free-swelling controls, but all three groups
were significantly different from each other, again showing a clear dose-dependency.
In a parallel experiment, the use of the general caspase inhibitor Z-VAD-fmk and
the SmithKline Beecham manufactured inhibitor SB-279885 failed to significantly reduce
the amount of sGAG lost to the media for an injurious compression of 20 MPa peak applied
stress (Fig: 3-13).
3.2.1.3 Nitric Oxide Release
Since nitric oxide (NO) has previously been shown to induce apoptosis in chondrocytes [7],
levels of nitric oxide production were measured to assess whether NO was a component of
the transduction pathway associated with injurious compression. Looking at the cumulative
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Figure 3-13: The total sGAG lost to the media by day 4 following a 20 MPa peak stress
injurious compression on day 0 is shown for different apoptotic inhibitors. Z stands for Z-
VAD-fmk, SB stands for SB-279885. Data are meaniSEM; No changes were significant.
nitric oxide released to the media by day four of the dose response experiment of Fig: 3-
12, only the most severely loaded condition presented a significant increase in nitric oxide
production versus free-swelling controls (Fig: 3-14). It should be noted that the detection
limit of the Griess reaction is ~1 pM nitrite [66] in biological fluid, and that many of
the samples were close or even below this level. Therefore, the possibility of finite NO
production at the 6 and 10 MPa levels, but below the detection limit of the assay, remains.
The accumulated NO levels were also measured in the conditioned media for an ex-
periment involving the use of the general caspase inhibitor Z-VAD-fmk and the SmithKline
Beecham inhibitor SB-279885 (Fig: 3-15). The groups in this experiment were cultured in
different inhibitors and all exposed to a 20 MPa peak stress injury. The cumulative NO
release as of day 4 shows a non-significant (p=0. 13) trend toward decrease for the 25 pM
SB-279885 condition, but all other differences were not significant.
The NO levels from spent media taken from the cytokine experiment (see sec-
tion: 3.1.1.3) were also assessed for nitrite content and showed levels of NO that were
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Figure 3-14: The total nitrite found in the media by day 4 following injurious compression
on day 0 is shown for different levels of injurious compression. Data are meaniSEM, *
indicates p < 0.05 by paired t-test.
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Figure 3-15: The total nitrite found in the media by day 4 following a 20 MPa peak stress
injurious compression on day 0 is shown for different apoptotic inhibitors. Z stands for
Z-VAD-fmk, SB stands for SB-279885. Data are mean±SEM; 25 puM SB showed a non-
significant (p=O.13) trend toward decrease.
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Figure 3-16: The cumulative release of nitric oxide into the media is shown for disks treated
with 100 ng/ml TNF-a, 100 ng/ml IL-1#, both, and anatomically matched controls. Data
are mean±SEM, n=12,12,8,4.
40-70 times that of control disks for both TNF-a and/or IL-l3 (Fig: 3-16).
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Chapter 4
Discussion and Conclusion
4.1 Apoptosis Findings
The presence of nuclei staining positive for apoptosis via TUNEL demonstrates that inju-
rious mechanical compression can induce chondrocytes to undergo apoptosis in articular
cartilage. This effect was observed to be dose-dependent, with detectable increases begin-
ning at 4.5 MPa and close to 50% of chondrocytes staining positive at 20 MPa. Previous
studies of cartilage explants wounded by cutting [94, 99] have shown that cartilage tissue
assayed via TUNEL for apoptotic chondrocytes began to display positive staining of cells
as soon as 10 minutes following injury, showed a maximum staining at 2 days post-injury,
and retained positive staining cells for at least 20 days. These findings should also be rep-
resentative of in vivo studies, as articular cartilage does not possess phagocytic cells. In
light of this evidence, a detection window for apoptotic chondrocytes does not appear to
exist, and the analysis of injuriously compressed tissue at 4 days post-injury would not be
expected to be confounded by artifactual loss of apoptotic cells.
Preliminary results indicate that mechanically induced chondrocytic apoptosis is
not inhibited using the non-specific caspase inhibitor Z-VAD-fmk. This suggests that
chondrocytic apoptosis following injurious compression may proceed via a non-caspase
dependent mechanism, such as a mitochondria related pathway. Experiments involving
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chondrocytes isolated from growth plate tissue have demonstrated that the expression of
the mitochondria associated anti-apoptotic protein Bcl-2 is reduced in cells subjected to
serum withdrawal and retinoic acid [26]. A similar response may be occuring in injuri-
ously compressed cartilage.
Currently, all assessment of apoptosis in this thesis has been done using the TUNEL
assay. While the TUNEL assay is generally considered to be a reasonable measure of apop-
tosis, it does have the possibility of staining necrotic DNA [33]. It can be imagined that
DNA from necrotic cells, while not condensed and no longer bound inside of a nuclear
membrane, may be insufficiently degraded to diffuse out of the lacuna into the ECM and
give rise to false positive signals. Additionally, the failure of caspase inhibitors to pre-
vent apoptosis could just as easily be explained by necrotic cell death as a mitochondrial
pathway. Without electron-microscopy (EM) studies to look at the cell morphology (the
definitive test of apoptosis) and DNA laddering via agarose gel electrophoresis, the most
convincing supporting evidence of chondrocytic apoptotic cell death is other studies show-
ing apoptotic chondrocytes in similar conditions [94, 99, 20] that have used EM, TUNEL,
and Annexin V staining.
4.2 Viability Findings
Vital dye staining of injuriously compressed cartilage tissue yielded results that closely fol-
lowed those of the apoptosis studies. In most cases the viable and non-viable cells were
interspersed among each other in a fashion similar to that found in previous studies [81].
Viability results were consistent with a previous study on calf cartilage tissue [81] but were
reduced at peak stresses lower than what was needed to reduce viability in young (16-20
month) bovine tissue (0.2 J, drop tower injury) [54] and adult human tissue (20 MPa, strain
of 25%, strain rate of 500/s) [83]. A time course study looking at vital dye staining of
20 MPa injuriously compressed tissue as a function of time following compression showed
no significant changes between directly after, one day, two days and six days after com-
pression. This result again validates the stability of non-vital cells inside of the ECM, and
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it also points out that much shorter post-incubation times than the current four days could
likely be used. The correspondence between the vital dye staining and the TUNEL la-
belling results indicate that the apoptotic cells are most likely staining as red by the time
of analysis. Whether apoptotic chondrocytes will stain green, green and red, or red with
ethidium bromide(red)/fluorescein diacetate(green) is currently unknown, but it will de-
pend on how long it has been since the apoptotic event has occurred. From these results, it
would appear that apoptotic chondrocytes begin to stain exclusively red before the end of
the compression, and vital dye staining has the potential of serving as an effective primary
assay for analyzing new conditions within this injury model.
4.3 Changes in Biochemical Properties
Wet weight increases and sGAG loss both increased in a dose-dependent manner. The
sudden increases in tissue wet weights that were observed following injurious compression
(within 1 day) indicate collagen network damage from the physical trauma [81] rather than
cell-mediated proteolysis. The increased sGAG release rates, observed for two to three days
following the more severe compressions, are also consistent with collagen network damage.
The increase in sGAG release can be at least partially attributed to increased proteoglycan
diffusivity due to the greater effective pore size of the damaged collagen network [55].
Previous researchers have found evidence for a nitric oxide (NO) related pathway
in chondrocytic apoptosis [7, 45]. NO release from injuriously compressed tissue was
elevated from control at the 20 MPa peak stress compression level but was very close to the
detection limit of the assay and still far below the NO levels induced using either TNF-a
or IL-l#. While these results did not rule out an NO mediated pathway at this time, they
do not lend much weight to this hypothesis.
61
4.4 Conclusions
In an effort to understand the conditions under which apoptosis occurs in articular car-
tilage, an in vitro model system was developed to study chondrocyte apoptosis induced
by injurious compression of articular cartilage. The apoptotic response corresponded well
with other markers of tissue damage, including tissue swelling, sGAG loss, and vital dye
staining. Interestingly, this apoptotic response was detectable under loading conditions
(4.5 MPa peak applied stress) below what was need to produce detectable changes in vi-
ability (10 MPa), sGAG loss (6 MPa) and wet weight (13 MPa). Therefore, the threshold
mechanical loading responsible for induction of chondrocyte apoptosis may not necessarily
be the same as for damage of the ECM.
The finding of increased numbers of apoptotic cells in OA tissue [59, 6, 42] indi-
cates a possible role for aberrant apoptosis in the pathogenesis of OA. At what point this
role would come into play is currently unknown. The present results indicate that mechan-
ical compression alone is sufficient to induce chondrocyte apoptosis in articular cartilage,
and this leads to the interesting hypothesis that injurious joint loading could cause chon-
drocyte death even in the absence of other observable changes to the tissue. This apoptosis
mediated cell loss could then lead to the remaining chondrocytes being too few in number
to counter the normal catabolic metabolism of the ECM, resulting in subsequent degra-
dation of the tissue into OA [1]. Conversely, fibrillation of the cartilage tissue exposes
the chondrocytes to non-physiological levels of mechanical stress and would also lead to
apoptosis. In both cases, the induction of apoptosis could be ascribed to mechanical com-
pression, but in the second case apoptotic chondrocytes come about as a secondary result
of OA and are not the primary cause.
The stresses that were applied to the articular cartilage tissue disks in this the-
sis matched the range of physiological stresses felt by articular cartilage in vivo (0-
20 MPa) [48]. However, other studies have noticed that removal of cartilage from bone
has an amplifying effect on tissue damage [54], and the removal of the superficial layer
will also expose the tissue to greater damage. Since the stress levels in this injury model do
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not map directly to physiologic stress levels, it is difficult to distinguish between the two
hypotheses presented for the in vivo findings of apoptotic chondrocytes in OA tissue from
the in vitro data presented in this thesis. One advantage of the injury model developed in
this thesis is that it is a pure cartilage system, and the effects of non-chondrocytic cells do
not need to be accounted for.
The biological pathway through which articular chondrocytes are induced to un-
dergo apoptosis is currently unknown, but several hypotheses have appeared in the litera-
ture including binding of CD95 [44], elevated levels of NO [6, 7], and loss of extracellular
matrix survival signals [42, 45]. This last hypothesis is the most consistent with a mechani-
cal origin of the initial apoptosis inducement signal, as a mechanical insult could cause the
chondrocytes to be detached from these survival-promoting ECM signals. An alternative
hypothesis that is also consistent with a mechanical origin and the lack of caspase inhibitor
effects is mechanically induced mitochondria damage. In many ways, mitochondria act as
stress sensors for cells, and mechanical damage to the mitochondria could cause release
of cytochrome c into the cytosol and/or interfere with the normal anti-apoptotic ability of
Bcl-2.
4.5 Future Experiments
The full potential of the in vitro cartilage injury model developed in this thesis is not close to
having been reached. Many open ends remain, and every answer asks many more questions.
" A confirmatory experiment needs to be done to verify the results of the TUNEL
assay for this cartilage explant system. Agarose gel electrophoresis to look for DNA
laddering (preliminary results discussed in section: D.3) or electron microscopy to
look for characteristic changes in morphology would serve as conclusive checks of
the validity of the TUNEL assay.
* The biological pathway along which the apoptotic process propagates in injuriously
compressed articular cartilage has not been identified. Although caspase activity is
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generally studied in cell culture systems, quantification of caspase activity in this tis-
sue culture system, if technically possible, would provide valuable insights into the
mechanism and propagation of the apoptotic response. Caspase inhibition studies
in this thesis have shown no effect, but other researchers have found that caspase
inhibitors, specifically Z-VAD-fmk [20], prevented apoptosis in injuriously com-
pressed cartilage. Further experiments with higher concentrations of Z-VAD-fmk
and other inhibitors should be attempted. Finally, looking for cytochrome c and/or
Bcl-2 might provide information on whether this apoptotic response is proceeding
via a mitochondria regulated pathway.
" The current method for detection of apoptotic nuclei is time intensive and does not
readily provide a quantitative number. Other methods for apoptotic analysis, such as
TUNEL analysis via flow cytometry D. 1, would be useful and should be developed.
" The current injury model, while useful, is not directly physiologically relevant. Car-
tilage deformation upon loading of intact joints is not directly comparable to either
unconfined or confined compression but is somewhere inbetween. Applying con-
fined or unconfined compression to full thickness cartilage-bone cores would be more
physiologically relevant due to the intact superficial layer and support provided by
the underlying bone. Additionally, the peak stresses generated in such an experi-
ment would correspond more closely to the stresses generated in the physiological
condition and in osteochondral autograft surgeries.
* Finally, the injury model has not yet been used in any real capacity to examine the
effects of tissue injury on possible degeneration of cartilage tissue into OA. Many
experiments using this injurious compression model can be envisioned, including ex-
amining the role of matrix metalloproteinase (MMP) activity using techniques such
as immunocytochemistry or Western blotting and looking for gene (up and down)
regulation using techniques such as differential mRNA displays and Atlas blotting.
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Appendix A
The Incustat and its Controller
A.1 Introduction
Previous compression studies in this lab have made use of dynamic mechanical spectrom-
eters (dynastats) or static compression chambers (Fig: A-1) for the mechanical loading
of cartilage tissue. While the dynastats provide extremely accurate and precise dynamic
movement, their large size makes them impractical to maintain inside of a sterile envi-
ronment and therefore limits dynamic loading experiments to short time spans. The static
chambers, on the other hand, can be autoclaved and used inside of sterile incubators, but
they are not as accurate and cannot provide true dynamic loading.
The solution has been to construct a miniature dynastat that can fit inside an incu-
bator (hence, incustat, also called the CA2000) (Fig: A-2). This apparatus was originally
conceived so as to allow for dynamic compression experiments longer than one day (ex-
periments in which the use of dynastats would have created a serious risk of infection).
The machine has also proven extremely useful for the application of the injurious compres-
sion protocols used in this thesis, as it has the ability to apply a controlled and monitored
mechanical load to cartilage tissue within a sterile environment, thereby allowing for post-
compression culturing.
The incustat (Fig: A-3) was constructed by Dr. Eliot Frank and consists of a high-
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Figure A-1: A typical static compression chamber. These chambers have been used in both
static loading experiments and previous injurious compression experiments. Note the hole
in the center of the chamber through which the LVDT passes.
precision stepper motor connected through a worm gear to a loading frame, allowing the
loading frame to move up and down so as to apply load to a polysulfone chamber contain-
ing the cartilage disks. The chamber used is identical to the ones used for static loading
experiments (Fig: A-1). A load cell is connected between the chamber top and the loading
frame, and measures the applied load. A linear velocity displacement transformer (LVDT)
is connected between the loading platform and the load cell, going directly through the
center hole of the compression chamber (see Fig: A-1). This arrangement allows direct
measurement of the thickness of the chamber and side-steps some of the problems encoun-
tered with machine compliance.
A.2 Non-inearities
As built, the machine suffered severe performance problems arising from backlash in the
motor train. This nonlinearity was unaccounted for in the original feed-forward control
design and was only partially compensated for by the later addition of springs. Besides
not fully correcting the problem, the springs limited the range of the device and more
importantly for injurious compression experiments, reduced the maximal load that could
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Figure A-2: The incustat machine inside a standard cell culture incubator. The chamber in
the machine is being compressed. The chamber to the right of the incustat is being used as
a static control.
be applied to tissue samples.
A.3 Feedback Compensation
A better solution than the use of springs in the gear train is feedback compensation to elim-
inate the system's nonlinearities (Fig: A-4). This feedback was originally accomplished
through software control, and a further improved hardware implementation of the feedback
loop has been built and incorporated into the current design (CA2000, Fig: A-6) and the
second generation (CA2001) incustat machines. A schematic of the feedback loop is shown
in Figure: A-5.
The feedback allows the full loading capabilities of the machine to be used in in-
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CA-2000 Compression Apparatus
12"
16"
sample Chamber
Aluminum Plates
(4) 12" x 9" x 1/2"
Figure A-3: Schematic drawing of the incustat showing stepper motor, loading frame, load
cell, and the compression chamber. The displacement transducer (not shown) is positioned
between the load cell and the plate the sample chamber rests on, passing through the center
of the compression chamber.
jurious compression experiments by eliminating the need for springs in the design. The
maximum load of the machine has been further increased by the removal of a 35 kg hard-
ware cut-out, allowing the machine to induce loads up to the stepper motor stalling level
of -45 kg. Additionally, the feedback improves performance sufficiently that the rate of
compression can be precisely controlled and sinusoids at any frequency can be imposed for
the purposes of dynamic compression experiments.
The feedback control scheme in both the hardware and software version is a sim-
ple proportional compensator. Solving for the transfer function of the feedback system in
Figure: A-4 yields:
Y(s) K1K 2H1(s) (A.1)
X = H(s) = (A.1)X(s) 1 + K 1K 2H1H2 (s)
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Figure A-4: Diagram showing the basic components of the hardware feedback scheme. H 2
is assumed to be linear, and a proportional gain is used for the amplifier G.
where H1(s), representing the transfer function of the stepper motor, is not known,
but can be expected to be nonlinear, H2(s), representing the LVDT, is approximately unity,
and K1 and K2 , the 2 points of feedback adjustment, are assumed to be proportional and
can be combined as one gain, K.
To linearize the system as a whole, K is increased, which allows the system transfer
function H(s) to go to 1. Empirically, it has been found that to maintain stability in the
software case, the gain K must be set to less than unity. This limit on stability arises from
the non-linear delays involved in data acquisition, software computation, and data output.
In the hardware feedback case, the delay in the system is essentially non-existent and an
upper limit on stability for K has not been reached.
A.4 Software Issues
The hardware feedback implementation for controlling the incustat has demonstrated very
satisfactory results. However, there are currently several issues with the available soft-
ware for controlling the incustat machine that makes full use of the machine's capabilities
slightly more complicated.
Briefly, the "Incustat Controller" program is currently at version 1.5 and does an
adequate job of running scripts and saving and displaying data. The program does not make
use of the hardware feedback electronics and uses only software feedback to control the
machine, making it unsuitable for higher frequency sinusoidals (>0.1 Hz). Additionally,
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Figure A-5: A Schematic of the hardware feedback circuit. The AMPO3 is the instrumen-
tational amplifier used for generating the error signal. The CMPO1 is a simple comparator
and provides the directional bit for the stepper motor. The error signal is amplified with the
first OP2 and then rectified with the next two OP2's. Finally, the rectified amplified error
signal is converted to a pulse sequence with the voltage controlled oscillator chip AD654.
the program, while simple, has some usability issues, such as sinusoids needing to be done
at a DC level of 0 for optimal resolution, which requires manual zeroing of the LVDT to
the desired DC level.
There is an alpha level version 2.0 "Incustat Controller" that is approximately 80%
complete that was to incorporate both open and closed loop control, with both hardware
and software feedback, but development of this software was dropped leaving the program
in an unusable state when "Cassp" version 8.8 incorporated hardware feedback control.
"Cassp", while the most full-featured of the three programs and the only one not to
be written in Labview (a good thing), has several problems that still need to be addressed.
The DC level of sinusoids have a habit of drifting with time under "Cassp", which has led
to quite a few ruined experiments. Additionally, due to a design "feature" of the voltage-
controlled oscillator chip in the hardware feedback loop, the hardware feedback loop stalls
if the error signal goes over 1.5 V, a common occurrence in injurious compression exper-
iments. "Cassp" has no mechanism for recovering from such an occurrence, which limits
the program's usefulness for injurious compression protocols. Finally, "Cassp" provides
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Figure A-6: The incustat within its incubator along with the controlling computer and
electronic hardware. This is an old picture taken when an actual signal generator was used
to drive the hardware feedback circuitry in dynamic compression experiments.
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few mechanisms for viewing what is being done to the tissue in real-time.
Since the problems in "Cassp" are real show-stoppers, and the problems with ver-
sion 1.5 of the "Incustat Controller" are only usability and performance annoyances, the
"Incustat Controller" program has been used for all injurious compression protocols in re-
cent history. The problems in "Cassp" should, however, be fixed shortly and it is anticipated
that "Cassp" will be the only controlling software package maintained and used sometime
in the near future.
A.5 Calibration Procedures
Calibrating the incustat is more of an art of approximation then engineering. Several of
the factors that make precise calibration difficult include: (1) the compressibility of the
polysulfone chambers, (2) the aluminum plates on which the chamber sits and the alu-
minum plate the stepper motor is bolted to are not parallel, (3) machine compliance, due to
the "threaded rods and bolts" construction and choice of materials, and (4) tissue swelling.
While these factors make knowing exactly what you are doing to the tissue difficult, consis-
tent loading of explant tissue between different experiments and therefore consistent results
can be obtained by strict adherence to the following guidelines.
1. Use tissue that is between 1 and 2 days old. Cartilage tissue swells over time dur-
ing explant culture, so using the tissue soon after performing the explant minimizes
variability due to swelling. It also allows the use of a measured thickness at the time
of cutting to be used to offset the variability in thickness arising from the explant
sectioning process.
2. Calibrate the incustat so that 1 kg of load on the polysulfone chamber after stress-
relaxation corresponds to a displacement of 0 pm. Since the wells of the compression
chambers are 500 pm deep, in a perfect world 0 pm displacement on the machine
would correspond to 50% compression of a 1 mm thick cartilage disk (not the case,
see below).
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Figure A-7: Displacement is shown as a function of peak stress. All data comes from 1-2
day old tissue compressed in the incustat using the described calibration procedure. In the
fitted equation, x represents the desired peak stress and y the appropriate displacement.
One may note, as an example of the combined effects of the chamber compressibility
and machine compliance, that the difference between 1 kg of load on the empty poly-
sulfone chamber and 10 kg of load is around 100 pm. Therefore, for repeatability, it
is very important that zero should always correspond to the somewhat arbitrary 1 kg
of load on the chamber.
3. Examine Figure: A-7 to calculate the strain needed for the desired peak stress.
From examining Figure: A-7, one can see that compressing below the zero point is
necessary for higher level loading. While at first non-intuitive, one must keep in mind that
the offset load of 1 kg during calibration is fairly arbitrary, and zero does not correspond
to compressing the disk to 500 pm because of the previously mentioned problems with
the incustat and the chambers. In fact, when compressed to -100 pm using this calibration
scheme, the load is only around 10 kg due to compressibility and compliance.
Another important thing to realize is that in all experiments to date, any effects of
the chamber on the load reading have been ignored for the calculation of peak stress. The
main reasons are that the polysulfone chambers have their own stress-relaxation times, and
at the higher loads, the peak stress is often achieved before arriving at the final strain level,
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both of which make calculating the effects of the chamber on the peak stress difficult.
Other things to worry about include using the "Greg Allen" chambers (500 pm
deep well divets) and avoiding the "Tom Quinn" chambers (100pm deep well divets). In
the future, the "Tom Quinn" chambers might be preferable, due to their ability to compress
a 1 mm thick cartilage disk to more than 50%, but at the present, "Greg Allen" chambers
have been used and should continue to be used for consistency.
While there are problems with the current calibration procedure, adherence to the
current protocol will allow for repeatable results. In the future, several changes should be
made to enhance the repeatability of experiments. Use of the new incustats (i.e. version
2001) should avoid some of the mechanical compliance problems due to their more rugged
construction. Further, use of stainless steel chambers would reduce the compressibility
problems of the current chambers. Finally, updates to "Cassp" should allow for hardware
feedback to be used in injurious compression experiments and further remove problems
with non-linearities.
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Appendix B
Quantitative Analysis of Ethidium
Bromide and Fluorescein Diacetate
Stained Cartilage Tissue Sections
B.1 Introduction
When running experiments using tissue or cell culture systems, the viability of the cells
is a parameter of great interest. In most cases, such as checking that cells are alive before
beginning an 8 week metabolic experiment, a qualitative assessment of the viability is more
than sufficient. In certain experiments, however, a quantitative analysis of the cell viability
is desirable. An example of this would be animal models and tissue systems used for
studying osteoarthritis, such as in this thesis, where the effect of mechanical insult on the
viability of the chondrocytes needs to be assessed and correlated to the level of damage.
There are many ways to measure cell viability. As the relative advantages and dis-
advantages of all these different methods are outside the scope of this thesis, the interested
reader is referred to the Molecular Probes web page for further information. Image en-
hancement will be applied using the Ethidium Bromide (EtBr) and Fluorescein Diacetate
(FDA) method, better known as the red/green assay [2, 87].
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Figure B- 1: Excitation and Emission Spectra of intercalated Ethidium Bromide. The exci-
tation peak is ~5 10 nm, the emission peak is ~ 6 10 nm.
In this method, either cells or thin sections of tissue are immersed in a solution
containing EtBr and FDA. EtBr cannot diffuse through the cell membrane of viable cells
and only diffuses through the cell and nuclear membranes of non-viable cells. Once in
the nucleus, EtBr intercalates with the chromosomal DNA, enhancing fluorescence 30-40
fold and shifting the excitation maxima ~3040 nm to the red and the emission spectra
~15 nm to the blue. At an excitation of 490 nm, bound EtBr has an emission maxima
at ~610 nm (Fig: B-1). FDA, in contrast, diffuses into all cells. However, only viable
cells contain active lipases, which break FDA down into fluorescein. Fluorescein has an
excitation/emission maxima of ~494/520 nm (Fig: B-2).
In short, under a fluorescent microscope using the appropriate filters, the nuclei of
dead cells will fluoresce reddish-orange, while live cells will fluoresce green.
There are several major problems with this method. First, fluorescein leaks out of
cells, creating a background green fluorescence that rises rapidly with time. This is es-
pecially apparent with tissue sections, where the slide may be intelligible for less then 2
minutes. Second, fluorescein exhibits photo-bleaching, which takes place on a time scale
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Figure B-2: Excitation and Emission Spectra of Fluorescein. The excitation peak is ~490
nm, the emission peak is ~ 520 nm.
of tens of seconds at higher magnifications. Third, the EtBr staining is concentration de-
pendent, and at high concentrations EtBr will also diffuse into viable cells. Nevertheless,
this method is still quite popular for two main reasons. First, the results are vivid and easy
to quickly interpret. Second, and far more importantly, EtBr and FDA are astoundingly
cheap (The total cost of the EtBr and FDA used in an average experiment is on the order of
40 p$).
There are two products put out by Molecular Probes that may be of interest for those
looking to measure viability. The first, calcien AM, behaves quite similarly to FDA, with
the added advantage that it has a relatively high cellular retention, reducing background
fluorescence greatly. Ethidium homodimer is similar to EtBr but binds to DNA about 1000
times stronger than EtBr. Currently, both products are expensive enough to prohibit them
from casual lab use. Additionally, work by Greg Allen has demonstrated that calcien AM
has an extremely slow diffusion time compared to FDA.
The goal of this project will be to process images taken of EtBr/FDA stained tissue
sections to improve the intelligibility of the images and to facilitate quantification of cell
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viability. To achieve this, several issues need to be addressed:
1. The images contain high levels of background staining from unbound EtBr and fluo-
rescein that has diffused out of cells.
2. The tissue sections are extremely thick (100-200 pm), so only a fraction of the cells
will be in focus, the rest adding background noise.
3. The variability in image intensity varies greatly from slide to slide. This variability
arises mainly from differences in the thickness of sections and in the amount of time
between immersion in the EtBr/FDA solution and viewing the slide.
B.2 Methods
All cartilage tissue was explanted from the femoropatellar groove of freshly slaughtered
calves, processed into groups of 3 mm diameter x 1 mm thick disks, and maintained in
low-glucose, 10% serum-supplemented DMEM with ascorbate (20 pg/ml=.1 mM) and
gentamicin antibiotic (50 pg/ml). Following an equilibration time (1-5 days), disks were
subjected to an injurious compression protocol. This consisted of compressing a disk to
50-70% of cut-thickness under displacement control, holding at the compressed level for
5', releasing for 25', and repeating for a total of 6 x. Free-swelling disks acted as controls.
After a variable amount of time post-compression (0-6 days), small vertical sections
(100-200 pm) were taken from the disks with a razor blade. The section was immersed
on a slide in PBS w/ 18 pM EtBr and 150 pM FDA for ~30 seconds before viewing
on a fluorescent microscope. A 450-490 nm excitation filter was used with a 520 nm
barrier filter on the emission. Photographs were taken immediately on ISO 100 slide film.
Processed slides were scanned with a Nikon CoolScan slide scanner and saved as JPEG's.
All subsequent image processing was done on SGI Indy computers using Matlab version
5.1. The images were trimmed when necessary to remove edge effects of the filtering
operations.
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B.3 Image Processing & Results
The basic process outlined so far is: Stain tissue with fluorescent compounds > Photo-
graph > Scan the slide film > Save the image > Load into Matlab. This series of actions
creates a system with an unknown amount of noise and distortion. The goal was to en-
hance the image so as to minimize the effects of this noise and distortion and facilitate
quantification of the cell viability.
When scanned into the computer, the image was stored as an RGB color-indexed
image. Each channel in the RGB image represented a sampled color of a different
wavelength. The red, green, and blue channels represented samples at wavelengths of
A = 700 nm, 546.1 nm and 435.8 nm, respectively (Fig: B-3). However, the colors of in-
terest from the fluorescence of DNA bound EtBr and fluorescein had peak wavelengths of
610nm and 520nm and wide spectrums that overlapped, as shown in Figures: B-1 and B-2.
This meant that each of the RGB samples at A=700 nm, 546.1 nm and 435.8 nm represented
a combination of the EtBr and fluorescein spectrums. In order to process the EtBr and fluo-
rescein components separately, the color portions of the RGB image corresponding to each
chemical needed to be determined.
For any given pixel, the intensities of the red, green, and blue components depended
on the relationship between the emission spectrums of EtBr and fluorescein and the absorp-
tion spectrums of the photographic film and scanning equipment. Rather than characteriz-
ing each of these spectrums, it was assumed that the intensity of the RGB components was
directly proportional to the value of the emission spectra at the RGB peak wavelengths, and
these values were simply read off of the graphs in Figures: B-1 and B-2.
Examining the emission spectra, it was apparent the EtBr spectrum completely
dominated the red component of the scanned image, as the fluorescein had virtually no
fluorescence at A=700 nm. As a result, the red component of the image was taken to be a
scaled representative of the EtBr distribution in the tissue section:
Red = x * EtBr (B.1)
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Cartilage Tissue Section
Green Component Blue Component
Figure B-3: The original image to be used as an example along with its red, green, and blue
components.
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Red Component
0 < X < 1
The green component of the image, however, was at A=546.1 nm, a wavelength
at which both fluorescein and EtBr fluoresce. This meant that the green color component
represented a linear combination of the light fluoresced by EtBr and the light fluoresced by
fluorescein. The intensity of the green samples was modeled using the following equation:
Green = y * EtBr + z * f luorescein (B.2)
0< y <1,0< z <1
Equations: B. 1 and B.2 form a linear system that can be solved to extract an im-
age that more closely corresponds to the fluorescein component of the tissue section. For
simplicity, x was chosen to be 1, as the actual magnitude of the image was not of real im-
portance. Similarly, z was chosen as 1. The remaining constant, y, was found by examining
the emission spectrum of EtBr. Continuing the approximation that the RGB components
were directly related to the value of the emission spectra at the RGB peak wavelengths, the
ratio of EtBr at A=546.1 nm to EtBr at A=700 nm was measured to be ~ 0.25. Since x was
chosen to be 1, this ratio was the value of y, or the relative proportion of the green image
component that came from EtBr. Putting this into matrix form yields:
Red 1 0 EtBr
(B.3)
Green .25 1 fluorescein
The inverse of this equation is:
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EtBr 1 0 Red
(B.4)
fluorescein -0.25 1 Green
Separating the EtBr and fluorescein components of the image was now a simple
mathematical transform (Fig: B-4). Notice that the blue component was ignored when
performing this transform, since its information was redundant in the model.
The process of picking distinct cells in the image could now begin. In counting
cells, only the cells in a single focal plane of the cartilage section, which appear in sharp
contrast in the image, were of interest. Cells from higher and lower layers that appear as
low-contrast blurs in the image were ignored.
To remove the background noise that results from these blurred cells and back-
ground fluorescence, unsharp filtering was be used. Unsharp masking is akin to high-pass
filtering and helped to remove background coloration while maintaining the high frequency
components of the image (these should have been the in-focus cells).
The cutoff frequency of the low-pass filter was chosen so as to smooth out all in-
focus cells while still passing the background coloration for a specific region. By analyzing
images, it was determined that at the given level of magnification the nuclei of most non-
viable cells were approximately 6 pixels in diameter. Similarly, the size of in-focus viable
cells was approximately 16 pixels in diameter. Accordingly, a Gaussian low-pass filter
with standard deviation (6/2) = 3 was chosen to smooth out the in-focus nuclei in the EtBr
component, and a Gaussian low-pass filter with standard deviation (16/2) = 8 was chosen
to smooth out the in-focus viable-cells in the fluorescein component (Fig: B-5). Both filters
were chosen to be of size 21 x21 as a compromise between distortion, speed, and the area of
the image lost due to edge effects. The resultant smoothed EtBr and fluorescein components
were then subtracted from their respective image components.
Next, the cells and nuclei from the filtered images were picked out. This entailed
choosing which magnitudes of the unsharp filtered image corresponded to cells or nuclei
and which are merely noise or blurred objects. Since most of the blurring had already been
filtered out by the unsharp filter, simple thresholding was used to convert the 8 bit image
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Figure B-4: The original image along with its green component, the EtBr component, and
the fluorescein component.
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Figure B-5: Spatial and frequency perspectives of the Gaussian low-pass filters used for
the unsharp filtering. The EtBr filter has a u=3 and is 21x21. The fluorescein filter has a
o=8 and is 21x21.
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components to binary components. Experimentally, it was determined that in general the
best threshold values were 1/12 of maximum intensity in the filtered image component.
This method was used for both the EtBr and fluorescein components. The result of the
filtering and thresholding steps are shown for both the EtBr and fluorescein components in
Figures: B-6 and B-7.
This thresholding process worked reasonably well, but often allowed random bright
pixels to pass, or created holes in otherwise well-defined cells and nuclei. To remove these
imperfections, a smoothing operation consisting of an erosion to remove unwanted bits
followed by a dilation to restore the image was performed on both components (Fig: B-8).
For the EtBr component, the erosion and the dilation were done with a 3 pixel diameter
circle. For the fluorescein component, the erosion was done with a 5 pixel diameter circle
and the dilation was done with a 4 pixel diameter circle (Fig: B-9).
Once the erosion and dilation were completed, it was a simple task (MATLAB
even has a command for it) to count the number of cells in both of the processed image
components. These numbers can then be recorded to show the number of live and dead
cells in a particular slide and the ratio of cells that are alive (i.e. the viability).
Taking this one step further, the EtBr and fluorescein binary components were re-
combined into an enhanced image of the original slide (Fig: B-10). This image clearly
shows the distribution of live and dead cells in the tissue section without background and
blurred object noise. Notice the occasional dead cell in the core of the tissue section that is
visible but hard to discern in the original image, but clearly evident in the enhanced image.
B.4 Conclusion
The described method worked well on a variety of sample images with different levels
of viability and blurring. Two other examples (Fig: B-11) are shown. The first of these
examples highlights this technique's ability to pick up on EtBr stained cells that are usually
lost to the human observer among the strong green fluorescein background fluorescence.
The first example also displays an artifact of the slide scanner, appearing as a band of
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Smoothed Green Component
Unsharp Filtered Green Component Thresholded Unsharped Green Component
Figure B-6: The fluorescein component is shown, along with the results of the low-pass
filter, the unsharp mask, and then the thresholding.
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New Green Component
Smoothed Red Component
Unsharp Filtered Red Component Thresholded Unsharped Red Component
Figure B-7: The fluorescein component is shown, along with the results of the low-pass
filter, the unsharp mask, and then the thresholding.
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Original Red Component
Dead Cells, number=309
Green Component Live Cells, number=782
Figure B-8: The EtBr and fluorescein Components, along with the binary EtBr and fluo-
rescein components computed from an erosion and dilation of the thresholded, unsharp-
filtered components.
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Figure B-9: The erosion and dilation filters used to process the fluorescein and EtBr com-
ponents.
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Figure B-10: An enhanced image created by combining the binary EtBr and fluorescein
components into a full-color image.
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extremely low intensity along the top. It was assumed that the photography, slide scanning,
and image storing did not add any noise or distortion to the image, but the slide scanner
often added very visible artifacts to the scanned images that were not present on the slides.
This method does not try to address this problem, as it was felt this would be more easily
fixed by an investment in new equipment.
While filtering the images on computer takes longer than the visual qualitative as-
sessment that is usually used, this method represents a means of obtaining quantitative
viability measurement from EtBr/FDA staining. It should also be noted that this is only
one method of performing such a quantification. The color transformation, unsharp filter-
ing and smoothing were all well-suited to this sort of problem, but it is certainly possible
that other methods may work as well or better. In accordance with its goals, this project
has demonstrated successfully one method of enhancing and automatically quantitating the
results of an EtBr/FDA viability assay.
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Live/Dead = 1400/706 -> 66 % Viability
Original Image Live/Dead = 142/1011 -> 12 % Viability
Figure B-11: Two further examples of the image processing, showing the scanned slide
image, the newly generated image, and the calculated viability.
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Appendix C
Biomechanical Characterization of
Loaded Disks
C.1 Introduction
Biomechanical measurements of cartilage tissue provide an accurate and sensitive mea-
sure of the tissue's physical composition and status. Initial changes in the biomechanical
properties were measured for the injurious compression model. These biomechanical mea-
surements sought to examine the levels of peak applied stress at which tissue damage be-
gins, and to elucidate whether the damage was associated with the collagen network and/or
proteoglycan loss.
C.2 Methods
Cartilage disks were harvested and fed as described in sections 2.2.1.1 & 2.2.1.2. The disks
were then subjected to graded levels of injurious compression as described in section 2.2.2,
with anatomically matched disks serving as controls. Immediately after compression, the
loaded and control disks were placed into a protease inhibitor PBS solution containing
PMSF, leupeptin, and pepstatin with occasional use of E64 and/or Pefablock.
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The disks were allowed to equilibrate in the inhibitor solution for at least 30 min-
utes before mechanical testing, and testing was generally completed within 8 hours of the
completion of the loading protocol. Mechanical testing of the cartilage disks was done first
in uniaxially confined compression and then in uniaxially unconfined compression using a
Dynastat mechanical spectrometer (IMASS, Hingham, MA), as previously described [27].
For both testing modes the mechanical testing protocol was identical and consisted of a
series of ramp-and-hold compression steps, allowing stress relaxation after each compres-
sion. At 0.92 mm compressed thickness, a series of 5 pm amplitude sinusoids at 0.01,
0.03, 0.1, 0.3, and 1 Hz was applied [10]. Total testing time for each disk was 2 hours.
For both compression modes, a quadratic was fitted to the equilibrium stress versus equi-
librium strain data. The equilibrium modulus at a given strain level was then obtained from
the slope of the curve at that strain (strains corresponding to compressed thicknesses of
1 mm and 0.92 mm were examined here). The dynamic stiffness was calculated from the
dynamic load amplitude, normalized to dynamic strain amplitude and disk area.
C.3 Results
C.3.1 Equilibrium Moduli
The equilibrium modulus was calculated at 1 and 0.92 mm for both confined and uncon-
fined compression modes (Fig: C-1). Since the measured moduli exhibited specimen to
specimen variation between different experiments, it was useful to normalize the values for
injured disks to those of matched controls (Fig: C-2).
For confined compression testing of the injured tissue, no significant changes
were seen for any loading condition between loaded and control tissue, although a non-
significant trend toward decreased stiffness was observed.
In contrast, unconfined compression testing showed significant reductions in the
equilibrium moduli of the injured tissue. For the equilibrium moduli calculated at 0.92 mm,
these changes were significant at peak applied stresses of 12 and 24 MPa, with -30% and
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Figure C-1: The equilibrium moduli are shown for loaded disks at four different peak
stresses versus uninjured controls, computed from confined and unconfined compression
tests at 1 mm and 0.92 mm. HA designates confined compression mode equilibrium
modulus. Ec designates unconfined compression mode equilibrium modulus. Data are
mean±SEM; * indicates p < 0.05 by paired t-test, + indicates p < 0.05 by t-test assuming
equal variances.
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Figure C-2: The equilibrium moduli normalized to the average of the control values are
shown versus peak injury stress, computed from confined and unconfined compression
tests at 1 mm and 0.92 mm compressed thicknesses. Data are meaniSEM; * indicates
p < 0.05 by paired t-test, + indicates p < 0.05 by t-test assuming equal variances.
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-60% reductions respectively. No significant differences were seen for the 3 and 7 MPa
conditions.
C.3.2 Dynamic Stiffness
The dynamic stiffness was calculated for the frequencies used in the mechanical testing
protocol (0.01, 0.03, 0.1, 0.3, and 1 Hz, Fig: C-3). Since the measured stiffness showed
specimen to specimen variation between different experiments, it was again useful to nor-
malize the values for injured disks to those of matched controls (Figs: C-4 & C-5).
For confined compression, the dynamic stiffness was significantly lower (-50%)
only for the most severe case (24 MPa), and then only at 1, 0.3, and 0.1 Hz. A non-
significant trend toward degraded stiffness could be observed.
In contrast, unconfined compression tests showed large and significant reductions
in the dynamic stiffnesses of the injured tissue. At 0.01, 0.03, and 0.1 Hz, the injured tissue
exhibited a significantly reduced (15-20%) stiffness at just 7 MPa. At higher peak applied
stresses, all differences were significant, with the 12 and 24 MPa loading conditions show-
ing a 50-60% and 90% reduction respectively at all frequencies. No significant differences
were seen for the 3 MPa condition.
C.3.3 Other Measurements
Streaming potential measurements were taken during the confined compression tests. How-
ever, due to poorly conditioned electrodes and inter-experimental variation, these numbers
had large associated errors and showed no significant differences.
C.4 Conclusion
The measured moduli and stiffness values showed large amounts of inter-experimental
variation arising from joint to joint and specimen to specimen variation, combined with
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Figure C-3: Confined and unconfined compression dynamic stiffness measurements are
shown versus frequency for disks loaded at different peak injury stresses. Data are
mean±SEM; * indicates p < 0.05 by paired t-test, + indicates p < 0.05 by t-test assuming
equal variances.
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Figure C-4: Normalized confined compression mode dynamic stiffness measurements are
shown versus peak injury stress at different frequencies. Data are mean±SEM, * indicates
p < 0.05 by paired t-test, + indicates p < 0.05 by t-test assuming equal variances.
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operator and experiment variability. While the raw numbers were difficult to compare, the
normalized numbers do show consistent, significant, and interesting trends.
To begin with, these tests show that a dose-dependent range of physical damage can
be inflicted on the cartilage in this injurious compression system. Further, these biomechan-
ical measurements show a clear decrease in stiffness for unconfined compression testing of
the tissue directly following loading that is not directly paralleled in the confined testing.
Since unconfined compression testing is more sensitive to collagen network damage than
confined compression testing, the results indicate that the initial damage is primarily to the
tissue's collagen network.
It would be interesting to study the change in biomechanical properties with time
following an injurious compression. Since the biomechanical testing was done directly
after testing, it is reasonable to expect that the proteoglycans may not have had time to
diffuse out of the newly weakened collagen matrix, and that the initial damage was seen
only in the collagen network. Given the sGAG loss rates in section: 3.2.1.2, one can postu-
late that significant differences in the confined compression testing values should begin to
show up 1-2 days following the injurious compression. Additionally, an experiment using
a protein synthesis inhibitor such as cyclohexamide would give information on whether the
tissue degradation is due entirely to the mechanical insult or if cell-mediated degradation
is occurring.
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Appendix D
Preliminary Results: Other Assays for
Apoptosis
Nobody wants a Charlie-in-the-Box - Charlie, on the Island of the Misfit Toys, from the
movie "Rudolph"
D.1 Flow Cytometry of TUNEL stained cells
D.1.1 Introduction
Flow cytometry (also often called FACS, for fluorescent activated cell sorting) is an often
used and often misinterpreted cell analysis method. Even with questionable interpretation,
flow cytometry can be fairly useful, but it would be well advised to have someone knowl-
edgeable in flow cytometry interpret results before publication.
In many respects a flow cytometry can be thought of as an automated fluorescent
microscope with a computer taking a quantitative assessment of single cells as they pass
by the laser. A typical flow cytometer uses a 488 nm laser and measures scatter, side
scatter, and fluorescence at 2 or 3 wavelengths. More advanced machines will have different
wavelength lasers, particularly UV, and often have cell sorting capabilities. Forward scatter
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is the laser light that refracts at a small angle (5 - 100) to the incident beam. Side scatter is
the laser light that reflects at a large angle (90 - 135') to the incident beam. Fluorescence
is generally measured off of the side scatter and is generally measured at red, yellow, and
green wavelengths. For more information on the history and current state of flow cytometry,
the interested reader is referred to Practical Flow Cytometry, 3rd Edition by Howard M.
Shapiro.
Since flow cytometry requires single cell suspensions, it tends to be more useful
when working with cell suspension or monolayer cultures, although cells from tissue are
sometimes examined by enzymatically isolating them from the tissue. In the chondrocyte
apoptosis literature, flow cytometry of freshly isolated, TUNEL labelled cells has been
used on several occasions [6, 42, 44, 45] although possible artifacts of the isolation process
have been noted [45].
While flow cytometry has detractions due to the loss of spatial information and the
possibility of artifacts from the isolation and fixation processes, the advantage of being
able to quickly and simply receive a quantitative assessment of apoptosis have made the
technique appealing.
D.1.2 Materials and Methods
Dithiothreitol (DTT), sodium nitroprusside (SNP), EDTA, cacodylic acid, protease,
paraformaldehyde, terminal transferase (TdT), fluorescein-12-dUTP (F-12-dUTP), and
bovine serum albumin (BSA) were obtained from Sigma, St. Louis, MO. Crude colla-
genase was obtained from Worthington, Lakewood, NJ. Camptothecin was obtained from
Oncogene, Cambridge, MA. All other materials were obtained as described in section: 2.1.
D.1.2.1 Tissue Harvesting
Articular cartilage tissue used for chondrocyte isolation was excised from the femoropatel-
lar groove of 1-2 week old calves with a scalpel, washed in explant PBS, and then further
processed as described in section: D. 1.2.3.
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D.1.2.2 Culture
Feed medium for isolated cells consisted of high-glucose, 10% serum-supplemented
DMEM with 10 mM HEPES buffer, 110 mg/ml sodium pyruvate, 0.1 mM non-essential
amino acids, 0.4 mM proline, 0.1 mM ascorbate acid (20 pg/ml) and gentamicin
(50 pg/ml). All media was changed daily.
D.1.2.3 Cell Isolation
Articular cartilage tissue used for chondrocyte isolation was minced, placed into a 20 U/ml
protease in feed medium solution (approximately 8 ml of solution per gram of tissue),
and placed in a 37 'C incubator. After two hours, the protease solution was aspirated
and the tissue was washed once with one volume of PBS. The tissue was then placed into a
200 Mandl U/ml Collagenase in feed media solution and placed on a rotary shaker table in a
37 'C incubator overnight. The following morning, the isolated cells were filtered through
100 pm and 20 pm filters, washed with one volume of PBS, and resuspended in DMEM.
Following the determination of cell viability via the red/green assay (section: 2.2.3.5) and
cell density using trypan blue and a hemocytometer, the cells were plated on tissue culture
plates at the desired densities.
When cells were isolated from cartilage tissue disks for flow cytometry, "overkill"
amounts of protease and collagenase solutions were used, the cells were not filtered at
the end of the isolation, and the cells were fixed immediately after isolation. In all other
respects, cell isolation from cartilage disks was identical to cell isolation from freshly ex-
planted tissue.
D.1.2.4 Red/Green Cell Viability Assay
Viability of cell suspensions was determined by adding ethidium bromide to a final concen-
tration of 18 pM and fluorescein diacetate to a final concentration of 500 pM to a sample of
the cell suspension. In cases where the cell suspension was at a high density, the suspension
was first diluted with PBS.
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D.1.2.5 Paraformaldehyde/Ethanol Fixation of Cells
Cells were either first isolated from cartilage tissue disks as described in section: D. 1.2.3
or removed from monolayer culture with the use of 0.25% trypsin in an EDTA solution.
The cells were then pelleted, washed with 1% BSA in PBS H Ca+++Mg++, resuspended
in 0.2 ml PBS H Ca++ +Mg++, added drop-wise to 1 ml 4% Paraformaldehyde (methanol
free) in PBS H Ca++ + Mg++for prefixation, and placed on ice for 20 minutes. The cells
were then washed again in 1% BSA in PBS - Ca+++Mg++and resuspended in 0.5 ml PBS
- Ca++ + Mg++. For fixation, the cell solution was brought to a final concentration of 70%
ethanol by the addition of ice-cold 100% ethanol while vortexing and were then stored at
-20'C for at least an hour before use. All centrifugation steps were done for 15 minutes at
300 g. At times, 5 ml 1% Paraformaldehyde was used for the prefixation step and 2% FBS
in PBS H Ca+++Mg++was used in place of the 1% BSA in PBS - Ca+++Mg++,
D.1.2.6 TUNEL Staining of Fixed Cells
In most instances, fixed cells were shipped on wet ice to SmithKline Beecham, where they
were analyzed using a commercially available TUNEL kit according to the manufacturer's
directions (ApopTag, Oncor, Gaithersburg, MD). Occasionally the assay was performed in
this lab using a protocol based upon information from the literature [42]. Fixed cells were
washed twice with PBS H Ca+++Mg++(centrifugation was for 10 minutes at 3000 g), re-
suspended in 50 pl labeling buffer (100 mM cacodylic acid, 1 mM CaCl2, 0.1 mM dithio-
threitol, 0.1 mg/ml BSA, 0.1 nmol F- 12-dUTP, pH'd to 6.7 with KOH), and incubated on
ice for 10 minutes. TdT (10 U) was then added, and the solution was incubated for 60 min-
utes at 37 C. The reaction was terminated by the addition of 2 pl 0.5 M EDTA. The cells
were then washed with PBS H Ca+++Mg++and resuspended in PBS H Ca+++Mg++in
preparation for flow cytometry. Flow cytometry was done immediately using a TUNEL
setup page for the flow cytometer (FACScan, Becton Dickinson, Franklin Lakes, NJ).
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D.1.3 Results and Discussion
Results on fixed chondrocytes that had been isolated from injuriously compressed tissue
4 days post injury and sent to SmithKline Beecham for flow cytometry have so far been
disappointing. A large decrease in cellularity for the more severely loaded conditions has
been observed directly after the cell isolation process, and it is currently believed that in the
overnight cell isolation process the apoptotic cells are being preferentially lost. Treatments
with 1 mM of the nitric oxide donor SNP for 12-24 hours on cartilage tissue, a condition
shown to induce chondrocyte apoptosis in monolayer [7], has also shown negative results
and low cellularity following digestion indicative of apoptotic cell loss during isolation.
There are a large number of protocols for isolating chondrocytes from cartilage, and some
should be assessed as possible replacements for the pronase/collagenase digestion protocol
when injuriously compressed tissue work is being done.
Monolayer experiments sent to SmithKline Beecham have also been mostly disap-
pointing. The problem here stems from the lack of a good positive control for apoptosis.
Chondrocytes have shown themselves to be unresponsive to many standard inducers of
apoptosis, including camptothecin and TNF-a with and without cyclohexamide. One pos-
itive result has been achieved by treatment with 1 mM of SNP for 12 hours, but this has
not been reproducible in tissue as noted above. Retinoic acid has been used successfully
in the literature to induce apoptosis in chondrocytes [1] and should be looked into for both
monolayer cultures and a possible apoptosis positive control for tissue work.
TUNEL assays performed in this lab on isolated cells have been completely unsuc-
cessful. Due to a complete lack of F-12-dUTP incorporation in control and treated cells,
the batch of TdT being used is suspect. For anyone interested in doing the TUNEL assay in
this lab, it would be pertinent to eliminate uncertainties by starting with a commercial kit.
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D.2 Flow Cytometry of P1 stained cells
D.2.1 Introduction
Propidium iodide (PI) staining is often used to detect apoptosis via flow cytometry because
of the simplicity and ease of the method. The method is, however, not very sensitive and
prone to misinterpretation due to artifactual signal from cellular debris, and data from PI
staining should generally be regarded with suspicion. The PI method has been used before
for monolayers of articular cartilage chondrocytes [7, 6], but it apparently has never been
used correctly (explained below).
Flow cytometry using PI is usually used to determine how much DNA is in a cell
and is useful when looking at cell cycle distribution (i.e. how many in G1/GO phase vs. G2
and S Phase). The basic theory of PI staining for apoptosis is that apoptotic cells will lose
their oligonucleosomal DNA fragments following fixation, and when the cells are run on a
flow cytometry using a dye that stains for nuclear content (i.e. PI, ethidium bromide), the
apoptotic cells will appear as a hypodiploid peak. This hypodiploid peak should appear at
somewhere in the range of 50% of the diploid peak. The problem with the peak measured in
the articular chondrocyte literature is that the peak is usually situated an order of magnitude
below the diploid peak (i.e. at 10% of it's value). Most likely cellular debris is being
measured. Even if these peaks arose from an apoptotic process, the apoptotic population
would be greatly overestimated, as each apoptotic cell would be divided up into multiple
fragments.
D.2.2 Materials and Methods
PI was obtained from Sigma, St. Louis, MO. RNAse (DNAse free) was obtained from
Boehringer Mannheim, Indianapolis, IN. For all other materials please see sections: 2.1 &
D.1.2.
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D.2.2.1 Ethanol Fixation of Cells
Cells were either first isolated from cartilage tissue as described in section: D. 1.2.3 or
separated from monolayer culture with the use of 0.25% trypsin in an EDTA solution.
Cells were then pelleted, washed with PBS - Ca+++ Mg++(centrifugation was 10 minutes
at 300 g), resuspended in 70% EtOH, and stored at -20'C for at least an hour before use.
D.2.2.2 Nuclear Content Measurements
Ethanol fixed cells were then pelleted by centrifuging at 2000 g for 15 minutes, washed
once, and then resuspended in PBS - Ca++ +Mg++. RNAse (DNAse free) was added to
2.5 pg/ml, and the solution was incubated for 30 minutes at 37'C. Following the RNAse
treatment, propidium iodide was added to a final concentration of 50 pig/ml and allowed
to equilibrate for 10 minutes before flow cytometry. Flow cytometry was performed using
a nuclear-content setup page on a FACScan flow cytometer (Becton Dickinson, Franklin
Lakes, NJ) measuring channel 2 fluorescence.
D.2.2.3 Results and Discussion
Flow cytometry of PI stained cells did not produce any signs of apoptotic cells in injuri-
ously compressed tissue and SNP treated monolayer cells. While these experiments did
confirm that articular cartilage chondrocytes are non-dividing due to the total absence of a
G2 peak, this protocol has been completely unsuccessful in terms of finding a subpopula-
tion of cells with hypo-diploid peaks. The PI staining procedure is most likely having the
same problems as the TUNEL method, namely the selective loss of subpopulations of cells
during isolation.
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D.3 Agarose Gel Electrophoresis of Apoptotic DNA
D.3.1 Introduction
The use of agarose gel electrophoresis for the detection of apoptotic DNA is one of the
older and more conclusive methods of apoptotic detection. The general theory behind this
technique is discussed in section: 1.4.2.6.2. Gel electrophoresis has been used to detect
apoptotic DNA from chondrocytes in growth plate cartilage [108] and in monolayer [7,
26, 1]. To date, gel electrophoresis has not been used to identify apoptotic DNA from
chondrocytes in articular cartilage.
D.3.2 Materials and Methods
Proteinase K and glycogen were obtained from Boehringer Mannheim, Indianapolis, IN.
Gel loading solution (Type I), sodium acetate, Tris-cl, N-methyl arginine (NMA), and phe-
nol/choloroform/isoamyl alchohol (25:24:1) were obtained from Sigma, St. Louis, MO.
Sodium dodecyl sulfate (SDS) was obtained from BRL, Gaithersburg, MD. All other ma-
terials were obtained as mentioned in sections: 2.1, D. 1.2, and D.2.2.
D.3.2.1 Harvest, Culture, and Compression
Harvesting, feeding, injurious compression of tissue, and isolation of cells were conducted
as described in sections: D.1.2.2, D.1.2.1, D.1.2.3, 2.2.1.1, 2.2.1.2, and 2.2.2.
D.3.2.2 DNA Isolation
Cell pellets or cartilage tissue disks were incubated in a digestion buffer containing 100 mM
NaCl, 10 mM Tris.Cl at pH 8, 25 mM EDTA at pH 8, 0.5% SDS, and 0.1 mg/ml proteinase
K in a hot water bath at 60'C overnight. The samples were then thoroughly extracted twice
with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) (centrifugation was
10 minutes at 1700 g). The aqueous layer was taken, 1/2 volume of 3 M sodium acetate (pH
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5.2), 2 (original) volumes of 100% ethanol, and 5 pl of 20 mg/ml glycogen were added,
and DNA was recovered by centrifugation for 10 minutes at 1700 g. The pellet was then
washed with 85% ethanol, allowed to dry, and dissolved in 50 Pl TE buffer (10 mM Tris-Cl,
1 mM EDTA). 5 pL of 500pg/ml RNAse (DNAse free) were added, and the samples were
incubated at 37'C for 30 minutes. Gel loading solution (type 1) was added to the samples,
and the samples were run on a 2% agarose gel containing 1 pg/ml ethidium bromide at
50 Volts.
D.3.3 Results and Discussion
To date, all attempts at visualizing apoptotic chondrocyte DNA from injuriously com-
pressed tissue and treated cells using agarose gels have been unsuccessful. Injuriously
compressed and SNP treated cartilage tissue, along with SNP, IL-l#, IL-l# and DMSO,
TNF-a, camptothecin, and actinomycin D treated chondrocytes have all shown no evidence
of low molecular weight DNA. Use of F9 ATCC CRL-1720 cells, a murine mouse embry-
onal carcinoma testicular teratocarcinoma cell line, treated with 10 AM of cisplatin has
produced positive results (Fig: D-1, lanes 6 & 7).
The biggest problem with gel electrophoresis is that a relatively large percentage
of apoptotic cells are required for resolvable bands to appear. Since chondrocytes are non-
dividing, many of the more usual treatments used for inducing apoptosis in other cell types
will have no effect and producing a sufficient number of apoptotic chondrocytes even in
monolayer may be difficult. In cartilage tissue, extracting the DNA is made even more dif-
ficult by the low percentage of the tissue that is cellular. Although gel electrophoresis would
not be appropriate for normal experimental use, successful imaging of apoptotic DNA from
injurious compressed cartilage would serve as confirmatory evidence that chondrocytes in
injuriously compressed tissue are truly undergoing apoptosis.
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Figure D- 1: Agarose gel containing DNA from several different conditions. Note that the
picture was taken 12 hours after running the gel, and the DNA has diffused a little smearing
the bands. Lane (1) 100 bp DNA marker (2) (3,4,8) Chondrocytes, 2 mM SNP treatment
of 1E7 Cells (4) F9 Cells, Control (5) F9 Cells, Control, no RNAse treatment (6) F9 Cells,
10 mM Cisplatin treatment for 24 hours (7) F9 Cells, 10 mM Cisplatin treatment for 24
hours, no RNAse treatment, (9) Chondrocytes, Control (10) Chondrocytes, 5 ng/ml IL-1#
treatment for 24 hours (11) Chondrocytes, 5 ng/ml IL-10 and 500 mM DMSO for 24 hours
(12) Chondrocytes, 5 ng/ml IL-1, 500 mM DMSO, and 1 mM NMA (13) Chondrocytes,
2 mM SNP treatment for 24 hours (14) kbp DNA marker
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